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Reproductive development in female teleosts like rainbow trout starts with release of the 
sex steroid estrogen, necessary for synthesis of the egg yolk protein vitellogenin. Increase in 
estrogen secretion during these reproductive phases results in increased energy demands. Skeletal 
muscle serves as an immediate endogenous source to address energy demands during 
vitellogenesis and spawning due to which it undergoes rapid degradation resulting in water 
accumulation, poor fillet and low egg quality. An imbalance in protein turnover is observed not 
only because of rapid increase in degradative pathways but also due to decreased protein synthesis. 
These changes in protein metabolism in skeletal muscle were identified within 24 hours of E2 
exposure and confirmed in both in vivo and in vitro models. Normally during adult myogenesis 
myogenic precursor cells proliferate and differentiate further to form a mature muscle fiber 
resulting in either hyperplasty or hypertrophy or both in fishes. Signaling pathways and MRFs 
need to function in coordination with epigenetic factors and non-coding RNAs to positively or 
negatively regulate muscle synthesis. Interestingly, estrogen also influences the expression of 
miRNA and in turn their target genes. However, the effects of estrogen regulating protein 
imbalance in rainbow trout skeletal muscle is not completely understood. Hence studies to 
understand the influence of estrogen were carried out using juvenile, sexually immature fish. 
Juvenile rainbow trout were treated with either estrogen or vehicle and their skeletal muscle 
collected after 24 hours and 72 hours of treatment to understand the role of miRNA and DNA 
methylation in regulation of myogenesis. Findings from the miRNA study revealed diluted effects 
of estrogen after 72 hours of treatment, hence further studies were carried out with samples from 
24-hour post treatment.  
  
miRNAs play a crucial role in regulation of gene expression along with epigenetics. These 
are small non-coding RNAs with length ranging from 21-23bp mostly functioning as post-
transcriptional regulators of gene expression. Generally, they bind to the 3’ region of transcribed 
mRNA with a complementary region called seed sequence. These genes are called target genes of 
miRNA. A single miRNA can target more than one mRNA. Binding of miRNA to its target gene 
results in either translational repression or deadenylation or both. Deadenylation results in loss of 
RNA stability, which leads to its degradation. miRNAs express in tissue specific manner and those 
that express specifically in muscle are called myomiRNA. Various myomiRNA have been 
identified and studied for their functions. Estrogen influence the expression of miRNA and in turn 
their target genes. Therefore, rainbow trout skeletal muscle samples were sequenced for small 
RNAs to understand the effects of estrogen. Differentially expressed miRNA were identified in 
estrogen treated samples when compared to control. A total of 36 miRNAs were either upregulated 
or down regulated in E2 exposed skeletal muscle of which two were novel. Target genes of these 
differentially expressed miRNAs were identified followed by gene ontology enrichment. These 
target genes are involved in various biological and molecular functions including their role in 
 
signaling pathways, cell cycle, DNA methylation, signal transduction and transcription factor 
binding. Genes regulated by miRNAs were also involved specifically in proliferation and 
differentiation of myogenic precursor cells and degradative pathways. E2 induced expression of 
miR-17 and miR-20, which are important in regulation of cell cycle. Further gene expression 
analysis of myogeneic regulatory factor, Pax7 specific to MPCs confirms increase in their number 
with decreased expression of MyoD, specific to differentiation. Similarly, miR-23a revealed its 
role in maintenance of mitochondrial outer membrane permeability and post-transcriptional 
regulation of atrophic genes. Decreased expression of miR-23a with increase in permeability was 
supported by increased gene expressions including fbxo32, caspases 3a and 9 that are involved in 
atrophy and apoptosis respectively. Expression analysis of one of the novel genes, miR-nov-285, 
was performed to know its expression pattern in different tissues, highest expression was observed 
in testis. C-5 methylation of cytosine was one of the GO term that was enriched during the target 
gene analysis of this novel miRNA. Further regulation of Dnmt1 gene expression by this novel 
miRNA was confirmed by luciferase assay. All together these observations indicate that E2 
influences differential expression of various miRNAs which in turn regulate gene expression 
contributing to muscle metabolism.   
  
Reduced expression of MyoD was observed in our previous study and direct regulation of 
this differentiation factor was not observed by any of the differentially expressed miRNA. Since 
gene expression is also regulated transcriptionally by epigenetic mechanisms including DNA 
methylation, efforts were made to understand its role in reduced MyoD expression. Generally, 
DNA methylation reduces gene expression by directly blocking transcription factor binding or by 
recruiting other epigenetic contributors like histone deacetylases or histone methyltransferases. 
Three different CpG rich regions were identified in MyoD gene which were further amplified after 
bisulfite treatment and analyzed to understand the influence of E2 on DNA methylation. 
Remarkable differential methylations were also observed in non-CpG sites in exon1 of MyoD in 
addition to CpG sites. Exposure to E2 resulted in increased methylation of all the CpH 
methylations, which were also observed to be present in conserved motifs: c-Myc and Estrogen 
Response Element (ERE). Relative gene expression study revealed an increase in DNA 
methyltransferases, Dnmt1, Dnmt3a and Dnmt3b in E2 exposed skeletal muscle. These 
observations directed our study to understand the influence of DNA methylation at whole genome 
level. 
  
Whole genome bisulfite sequencing (WGBS) was performed with control and estrogen 
treated skeletal muscle samples using paired end sequencing. These analyses resulted in 
identification of differential methylations of various chromosomal regions in CG, CHG and CHH 
contexts. Most of the CHG and CHH methylations observed were less than 10% while CG 
methylations were well distributed across various rates per site ranging from 0%-10% to 90%-
100% of the total genome. Most of the cytosine methylations were mapped to unknown 
chromosome of rainbow trout genome, which is currently 80% of the total genome. 43 million CG 
sites were identified in the whole genome of which 304 thousand were differentially methylated 
in E2 sample when compared to control. About 818 regions show significant differential 
methylation with a difference of at least 80 percentage. Fifty percent of these regions were mapped 
to 208 genes involved in primary and cellular metabolic processes, cell communication, signal 
transduction, ion binding, transferase activity and are parts of various cellular organelles. They 
also regulate metabolic pathways including steroid hormone and purine metabolism. 
 
  
Overall these observations indicate the role of small RNA and epigenetic mechanism 
particularly DNA methylation involvement in regulation of rainbow trout skeletal myogenesis 
under the influence of E2. These gene regulations were observed within 24 hours of E2 treatment 
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 Rainbow trout belongs to salmon family and is cultivated in America, with its importance 
in food, recreation and research. These fishes require enormous amount of energy during 
vitellogenesis and spawning to address the need for yolk proteins synthesis. The expression of 
sexual hormone genes and their secretion consequently promote catabolism in rainbow trout 
(ARMOUR et al. 1997; SALEM et al. 2006b; SALEM et al. 2010a). These demands in fish like 
rainbow trout are either addressed by exogenous sources (feed) or endogenous sources (skeletal 
muscle). Derivation of energy from endogenous sources results in rapid skeletal muscle 
degradation (SALEM et al. 2006b; CLEVELAND AND WEBER 2011a) creating an imbalance in protein 
turnover. Supportive evidence for the effect of the sex steroids on protein turnover was well studied 
(CLEVELAND AND WEBER 2011a). The imbalance in protein turnover is because of both increased 
catabolic pathways and decreased anabolic pathways resulting in poor muscle quality (LOVE 
1960b).  
Somites from mesodermal layer contribute to primary phase of myogenesis during 
embryonic development. These somites proliferate and differentiate to become myogenic 
precursor cells (MPCs), while acting as a scaffold for secondary phase of myogenesis during 
embryonic development. Adult myogenesis starts with activation, proliferation, differentiation and 
maturation of myogenic precursor cells present as a reservoir between the basal lamina and 
sarcolemma of mature muscle bundle (SEALE et al. 2001). Unlike mammals (ROWE AND 
GOLDSPINK 1969) MPC differentiation and maturation either contribute to hyperplasty (increase 
in muscle fiber number) or hypertrophy (increase in muscle fiber size) in rainbow trout hence most 
of the fish exhibit indeterminate growth pattern throughout their life (STICKLAND 1983; HIGGINS 
1985; WEATHERLEY et al. 1988; KOUMANS et al. 1993; ALAMI-DURANTE et al. 1997; PATRUNO et 
al. 1998; MOMMSEN 2001). Myogenesis is a complex mechanism involving various signaling 
pathways, myogenic regulatory factors and epigenetic factors. During regeneration, general 
metabolism (turn over) or injury a coordinated interplay among different contributing mechanisms 
is required for maturation of MPC to muscle fiber.  
MYOGENIC REGULATORY FACTORS (MRFS) 
Myogenic regulatory factors are basic helix-loop-helix transcription factors which drive 
the process of myogenesis. Differential expression of these myogenic regulatory factors determine 
 3 
progression of MPCs (WATABE 1999). Myf5 is an important MRF playing a role in committing 
the satellite cells to myogenic lineage. MPCs are mitotically inactive cells expressing satellite cell 
markers Pax7 (HOLLWAY et al. 2007; SEGER et al. 2011), HGF receptor c-met (HOLLWAY et al. 
2007) and Syndecan-4 (FROEHLICH et al. 2013a).  Several knockout studies were performed in 
mice to understand the importance of Pax7 expression in satellite cells. Collectively they conclude 
Pax7 is necessary for the maintenance of satellite cells state (SEALE et al. 2000; OUSTANINA et al. 
2004; KUANG et al. 2006; RELAIX et al. 2006).  Absence of Pax7 expression lead to defective 
muscle differentiation as an effect of cell cycle arrest and precautious differentiation (GÜNTHER et 
al. 2013; VON MALTZAHN et al. 2013). Increased expression of Pax7 is also observed in satellite 
cells (OLGUIN AND OLWIN 2004). Hence Pax7 is determined as a marker for MPCs. Mitotically 
inactive MPCs enter proliferative phase to either result in self-renewal or further differentiate to 
myoblasts. High levels of Pax7 expression is observed in self-renewing cells (OLGUIN AND OLWIN 
2004) while differentiating cells exhibit increased expression of MyoD and decreased expression 
of Pax7 (ZAMMIT et al. 2004). Thus, MyoD is one of the major factor is determining the myogenic 
cell fate of MPCs (MEGENEY et al. 1996; WHITE et al. 2000). Expression of other myogenic 
regulatory factors including Mrf4 and Myogenin after proliferation and during differentiation 
marks the progression of differentiation process to form a myofiber (FÜCHTBAUER AND WESTPHAL 
1992; YABLONKA-REUVENI AND RIVERA 1994). Signaling molecules play a significant role in 
regulating the expression of these MRFs thus determining the fate of myogenesis.  
SIGNALING PATHWAYS INVOLVED IN MYOGENESIS 
Muscle regeneration is triggered by transduction of the signals, eventually resulting in the 
activation of different signaling pathways which further activate expression of myogenic factors 
responsible for muscle growth. Maintenance of MPCs in satellite cell state is regulated by TGF-β 
family members while transition from proliferative to quantile mitosis by hedgehog signaling. 
These signaling molecules regulate differential expression of MRFs. Markers of MPCs, Pax7 and 
Pax3 are downregulated and differentiation factor MyoD is upregulated by hedgehog in teleosts 
thus functioning as one of the major determining factor for myogenic commitment. Growth 
hormone and insulin regulate myogenesis by binding to receptor tyrosine kinase and initiating 
signaling cascade. IGF-1 pathway is myogenic (FLORINI et al. 1996) activating the expression of 
the different genes responsible for the synthesis of muscle, which is synthesized either by liver or 
 4 
specific tissues in response to the growth factors. IGF-1 pathway enhances myogenic proliferation 
and differentiation via RAS/RAf and PI3K pathways thus controlling MPC proliferation and 
differentiation respectively (BING-HUA JIANG et al. 1999).  
INFLUENCE OF ESTROGEN  
Response to estrogen in skeletal myogenesis of rainbow trout contrasts to that of rats, pigs 
and cow (REHFELDT et al. 2009b; KAMANGA-SOLLO et al. 2010b; CLEVELAND AND WEBER 2011a). 
Increased protein degradation with decreased protein synthesis was observed in rainbow trout. 
Activity of estrogen on a cell is either through genomic or non-genomic pathways. Estrogen 
transduces its signal in non-genomic means by binding to the estrogen receptors which in turn 
activate various signaling pathways or by binding to IGF-1 receptor (KAHLERT et al. 2000; TIAN 
et al. 2012). Estrogen activates various signaling pathways including MAPK (MIGLIACCIO et al. 
1996; WATTERS et al. 1997; ENDOH et al. 1997) and phosphoinositol 3-kinase pathway (CASTORIA 
et al. 2001). These signaling pathways eventually regulate gene expression by initiating a cascade 
of phosphorylation and de-phosphorylation reactions. The GH/IGF axis plays a major role in 
myogenesis (GABILLARD AND RESCAN 2013) which is disrupted in salmonids (HOLLOWAY AND 
LEATHERLAND 1997a; NORBECK AND SHERIDAN 2011b; HANSON et al. 2012; HANSON et al. 2014) 
as an effect of estrogen release during sexual maturation and decrease in IGF-1 (TAYLOR et al. 
2008).  A disrupted GH/IGF axis partially explains the imbalance in protein turnover in sexually 
maturing fish. Genomic pathways of estrogen activity involve activation of estrogen receptors. 
Two subtypes of estrogen receptors were identified in rainbow trout; ERα and ERβ, with isoforms 
ERα1, ERα2 and ERβ1, ERβ2 respectively. Differential expression of these receptors in various 
tissues were reported during sexual development of fish (SABO-ATTWOOD et al. 2004; FILBY AND 
TYLER 2005; NELSON AND HABIBI 2010; CHAKRABORTY et al. 2011; SHI et al. 2011; NAGLER et 
al. 2012; TIAN et al. 2012). These estrogen receptors either form homo or hetero dimers and act as 
transcription factors by binding to estrogen response elements on DNA. Sexually maturing 
salmonids show increased in muscle catabolism with increased estrogen levels (ANDO et al. 1986; 
SALEM et al. 2006b; CLEVELAND AND WEBER 2011a; CLEVELAND et al. 2012) or after estrogen 
treatment (NAZAR et al. 1991a; OLIN et al. 1991). Increase in catabolism is an effect of increase in 
protein degradation with decrease in its synthesis. Three different degradative pathways contribute 
to the process of proteolysis in fish, ubiquitin-proteasome pathway, cathepsins and calcium-
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dependent calpains along with protein degradation by caspases during apoptosis. Spawning 
rainbow trout shows an increase in ubiquitin ligases, cathepsins and apoptotic caspases 
(TOYOHARA et al. 1998; SALEM et al. 2006b) which might be the major degradative pathways 
during sexual maturation.  
Molecular regulation of myogenesis is also governed through transcriptional, post-
transcriptional and translational stages. A coordinated communication among these molecular 
mechanisms is necessary to regulate these mechanisms meticulously. miRNA and DNA 
methylation are key players in transcriptional and post-transcriptional regulation. Expression of 
certain miRNA is restricted to muscle and they are called myomiRs and these miRNAs regulate 
the gene expression of MRFs in different stages of myogenesis. miRNA not only targets the 
expression of genes (CHEN et al. 2006c) but also play a role in signaling pathways aiding in muscle 
cell proliferation and differentiation (ZANOU AND GAILLY 2013b). Similarly, gene expression is 
also regulated at transcriptional level by DNA methylation of carbon at 5th position of cytosine. 
Methylated cytosines either upregulate or down regulate gene expression depending on the region 
of gene structure. Majority of the studies reported DNA methylation to be a negative regulator of 
gene expression thus making it unavailable for transcription. Removal of these methyl groups 
through demethylating mechanisms would result in gene regulation (RAZIN AND RIGGS 1980). Role 
of DNA methylation in myogenesis was established in 1979, by using chemical inhibitors of DNA 
methylations which resulted in differentiation of fibroblasts to cells specific to muscle lineage 
(TAYLOR AND JONES 1979). The role of miRNA and DNA methylation in various aspects of 
myogenesis is discussed below.  
microRNA  
Small RNAs, particularly miRNAs are extensively studied as post-transcriptional 
microregulators of gene expression governing mRNA translation or its stability (NILSEN 2007). 
Recent studies provided evidence for their transport (HWANG et al. 2007) and nuclear existence 
(LIAO et al. 2010) suggesting functions other than translational inhibition. Similarly, the presence 
of miRNA in exosomes (VALADI et al. 2007) advocates their secretion and circulation through 
body fluids (GALLO et al. 2012; ZHOU et al. 2012; LV et al. 2013) to control gene expression in 
recipient cells (IGUCHI et al. 2010). Besides continuous efforts to understand various functional 
roles of miRNA, their biogenesis (reviewed in (KIM et al. 2009) is well established. Primary 
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transcripts of miRNA are either generated by transcription of individual miRNA genes or by 
processing of intronic regions. Most of the primary transcripts (pri-miRNA) are transcribed by 
RNA polymerase II which are further cleaved by Drosha to ~65bp hairpin precursor miRNA (pre-
miRNA). The pre-miRNAs are then exported to the cytoplasm by exportin 5 for further cleavage 
by dicer to ~22bp RNA duplex that are loaded on to Ago proteins to form a RISC complex. One 
of the strand from the RNA duplex remains (mature miRNA) on the RISC complex while the other 
is released and degraded. The mature miRNA binds to target mRNA by either perfect or imperfect 
base-pairing leading to translational repression or mRNA degradation. The earliest reports of 
miRNA in rainbow trout was reported in an effort to understand the role of regulatory small RNA 
during early embryogenesis (RAMACHANDRA et al. 2008a) and further miRNA profiling from nine 
somatic tissues including muscle was performed (SALEM et al. 2010d). Recent availability of trout 
genome sequence (BERTHELOT et al. 2014) led to the establishment of microtrout database 
establishing genome wide prediction of miRNA-mRNA binding (MENNIGEN AND ZHANG 2016). 
Various factors, including embryonic temperature and (JOHNSTON et al. 2009), feeding 
(BIZUAYEHU et al. 2016) affect growth in fish through miRNAs. Johnston and his colleagues 
(JOHNSTON et al. 2009) showed the transition of hyperplastic to hypertrophic growth patterns in 
zebrafish involving differential expression of miRNA with varied embryonic temperatures. 
miRNA mediate the effects of nutrition on gene regulation, studies in atlantic cod and grass carp 
support such regulation. Differential expression of endogenous miRNA when fish were fed with 
different diets and supplementation with Bacillus natto are observed in atlantic cod and grass carp 
respectively, ultimately changing muscle metabolism in fish.  
Functional regulation of miRNA in Muscle 
Myogenesis involves orchestrated interaction of various mechanisms involving signaling 
pathways and coordinated gene expression of various myogenic regulatory factors (MRFs). The 
role of miRNA in myogenesis was first established in Dicer mutant mice exhibiting reduced 
muscle miRNA, perinatal death and decreased skeletal muscle with abnormal myofiber 
morphology and apoptosis of myoblasts (O'ROURKE et al. 2007). This study establishes the 
important role of miRNAs in vertebrate muscle development. miRNAs with muscle specific 
expression and function are designated as myomiRNAs. The involvement of these myomiRNA in 
muscle precursor cell proliferation and differentiation is established in various studies (reviewed 
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in (GE AND CHEN 2011).  Nachtigall et al compared the evolution and organization of myomiRNAs 
in cartilaginous and bony-fish genomes through genome-wide comparative analysis and concluded 
synteny in myomiRs distribution (NACHTIGALL et al. 2014). 
miRNA targeting genes involved in muscle synthesis  
Transcription factors that play a central role in proliferation, differentiation and maturation 
of myogenic precursor cells are Myogenic Regulatory Factors (MRFs). Interactions of miRNAs 
with major MRFs and other metabolic genes fine-tune gene expressions consequently controlling 
myogenesis (CHEN et al. 2006b; RAO et al. 2006). Differential miRNA expression was observed 
during various growth stages in skeletal muscle of slow and fast growing Nile tilapia (HUANG et 
al. 2012a), within 17 and 29 days after hatching in Japanese flounder (FU et al. 2011), during 
various developmental stages from hatching to 2 years in common carp (YAN et al. 2012), and 30 
days post hatching to 3 years in ray-finned fish (ZHANG et al. 2017), indicating a stage specific 
diverse miRNA profile in skeletal muscle of fish.  Most abundant miRNA expressed in skeletal 
muscle are miR-1, miR-206 and miR-133a in various fish species including rainbow trout (SALEM 
et al. 2010d; KOGANTI et al. 2017a), zebrafish (MISHIMA et al. 2009), flounder (FU et al. 2011), 
sea bass (XIA et al. 2011), Nile tilapia (HUANG et al. 2012a), Chinese perch (CHU et al. 2013) and 
common carp (YAN et al. 2012) consistent with studies from other species. Interaction of miR-1, 
miR-206 and miR-133a with their target genes to regulate skeletal muscle cell proliferation and 
differentiation is well documented from studies conducted using mice and mouse cell lines C2C12 
and MEF (CHEN et al. 2006b; ROSENBERG et al. 2006; CHEN et al. 2010). These studies shed light 
on the regulatory network among the miRNA and MRFs. Mature miR-1 and miR-133 are derived 
from one polycistronic pre-miRNA targeting two different genes, miR-1 and miR-133 target 
histone deacetylase 4 which negatively regulates the expression of muscle specific genes and 
serum response factor which regulates muscle cell proliferation respectively (CHEN et al. 2006b). 
Additionally, muscle specific expression of miR-206 is controlled by MyoD (ROSENBERG et al. 
2006) which along with miR-1 targets and represses Pax7, muscle cells marker for proliferation 
(CHEN et al. 2010).  Regulatory expression of miR-206 by MyoD is also associated with the 
negative regulation of follistatin-like 1 and utrophin genes which are necessary for muscle cell 
differentiation (ROSENBERG et al. 2006). An increased expression of these three miRNAs (miR-1, 
miR206 and miR-133a) along with miR-21 was observed in common carp skeletal muscle with 
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increase in age from 30 day post-hatching to 2 years (CHEN et al. 2010; YAN et al. 2012). 
Continuous expression of these miRNAs indicates their functional importance in maintenance and 
growth of skeletal muscle. Same study (YAN et al. 2012)reported the existence of oocyte specific 
miRNAs which decreased expression after fertilization supporting the concept of maternal miRNA 
or dicer. miR-1 and miR-133 explain more than 54% of variation in regulating gene expression 
that influences myogenesis in zebrafish embryo. They mainly contribute to the disruption of actin 
organization in sarcomere assembly when down-regulated (MISHIMA et al. 2009). Few studies 
report miRNA involvement upstream to MyoD gene expression. Findings in tilapia and Chinese 
perch report regulation of MyoD expression by miR-203b and miR-143 respectively, both miR-
203b and miR-143 bind to the 3’-untranslated region (UTR) of MyoD suppressing its expression 
(YAN et al. 2013a; CHEN et al. 2014). Additionally, expression of miR-27a, miR-214 and miR-
222 after hatching and eventual loss in mature common carp indicates their role in myogenic 
precursor cell proliferation and differentiation (YAN et al. 2012). miR-222 is also reported to be 
highly expressed in muscle related tissues in Chinese perch (ZHU et al. 2015b). A member of 
transforming growth factor- and a negative regulator of myogenesis, myostatin is also regulated 
by miRNA. miR-181a-5p targets myostatin and down regulates its expression, hence regulating 
the performance of red and white muscles (CHU et al. 2013). miRNA-206 is also involved in 
negative regulation of IGF-1 expression in tilapia skeletal muscle regulating its growth (YAN et al. 
2013b). These findings suggest controlled regulation of myogenesis by miRNA in fish species.  
Muscle cell fate  
miRNA determine muscle cell fate very early during somitogenesis (FLYNT et al. 2007). 
Differential expression of miRNA targeting various genes responsible for muscle cell fate are also 
influenced by embryonic temperature in zebra fish leading from hyperplastic to hypertrophic 
growth transition. Let-7 family of miRNAs were up-regulated and miR-19 family, miR-130 and 
miR-9 were downregulated in fish experiencing hypertrophic muscle growth (JOHNSTON et al. 
2009). Fish exhibit distinct slow and fast muscles in comparison to mammals and studies using 
fish as model species report the role of miRNA in muscle cell type determination. Ubiquitously 
expressing miR-214 synchronizes Hedgehog signaling in zebrafish by translational repression of 
its negative regulator Su(Fu), thus coordinating a balance among slow and fast muscle cell types. 
Knockdown of miR-214 in zebrafish embryos led to the developed of less or no slow muscle cells 
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(FLYNT et al. 2007). Similarly, knockdown and overexpression of miR-3906 in zebrafish embryos 
changed fast muscle phenotype as miR-3906 maintains homeostasis of calcium ion concentration 
specifically in fast muscles. Knockdown of miR-3906 increases the expression of its target gene 
homer-1b which in turn up-regulates fast muscle specific gene fmhc4 and calcium sensitive gene 
atp2a1. All together, these changes cause a surge calcium ions concentration causing disorganized 
sarcomeric actin in fast muscle and swimming abnormality. However, over expression of miR-
3906 decreases calcium ion concentration, resulting in bent bodies and shortened tails (LIN et al. 
2013). Another important miRNA extensively studied for its involvement in muscle cell fate 
determination is miR-499. It is highly expressed in red skeletal muscle in Nile tilapia compared to 
white skeletal muscle (NACHTIGALL et al. 2015). Target gene analysis revealed down regulation 
sox6 and rod1 genes associated with slow muscle phenotype. A regulatory network involving 
functional repression of sox6 by miR-499 through Prdm1for the maintenance of slow-twitch 
muscle was also reported in zebrafish (WANG et al. 2011) allowing restricted expression of sox6 
in fast-twitch muscle. miR-181a-5p and miR-143 target genes myostatin and MyoD to control 
performance of different muscle cell types in vertebrates (CHU et al. 2013; CHEN et al. 2014).  
miR-222 in Chinese perch is abundantly expressed in white muscle which is regulated by 
nutritional status (ZHU et al. 2015b). Varied expression patterns of miRNAs were observed in slow 
and fast muscles in Pacu fish (DURAN et al. 2015) and Chinese perch (CHU et al. 2013), suggesting 
their importance in muscle cell type specification. All together these studies emphasize the 
regulatory mechanisms of miRNA in determining muscle cell fate either through involvement in 
regulatory networks, regulating gene expression or by maintaining ion homeostasis. 
Estradiol and dietary influence on miRNA that regulates myogenesis 
The complex regulatory coordination of miRNA and MRF to dictate either muscle 
precursor cell fate and/or muscle cell fiber type and/or synthetic or degradative pathways of 
myogenesis is subjective to feed and hormone induced miRNAs. The influence of estradiol on 
differential miRNA expression was well studied in human breast cancers (reviewed in (COCHRANE 
et al. 2011)). Estradiol is released only during sexual maturation in teleosts (LUBZENS et al. 2010b) 
which is essential for the synthesis of vitellogenin for oogenesis. Recent studies focusing to 
understand differential expression of miRNA influenced by quality of eggs in relation to post-
ovulatory age (MA et al. 2015), ploidy of female fish and its fertility (ZHOU et al. 2015), fish 
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follicular development and oocyte maturation (ABRAMOV et al. 2013), estrogen regulation of 
miRNA during vitellogenesis (COHEN AND SMITH 2014) and during gonadal development 
(PRESSLAUER et al. 2017) were reported. Physiological changes in skeletal muscle during these 
stages of sexual maturation is obvious and widely accepted (ANDO et al. 1986; CLEVELAND AND 
WEBER 2011a), though studies to understand the role of miRNA in fish are sparse. Our study 
focused to understand the direct influence of estradiol and reported differential expression of 36 
miRNAs including miR-133, miR-499 and miR-145 in skeletal muscle of rainbow trout (KOGANTI 
et al. 2017a). Differentially expressed miRNA and their target gene analysis showed that estradiol 
affected various processes that govern muscle precursor cell proliferation, differentiation, muscle 
growth and atrophy. Efforts to understand the effects of thyroid hormone influence on expression 
of histone deacetylase, HDAC4 lead to the discovery of miRNA regulation in muscle development 
of Japanese halibut (ZHU et al. 2015a). This study presents evidence of an interaction of signaling 
pathways, epigenetic regulators like HDAC4 and miRNAs (miR-1 and miR-133). Further studies 
to functionally determine these identified miRNA-mRNA targets in skeletal muscle under the 
influence of estradiol are necessary. More focused species specific studies in other teleosts are 
crucial to determine and pinpoint the exact roles of miRNA during sexual maturation in skeletal 
muscle. 
Skeletal muscle loss during sexual maturation in fish supports energy demands required 
for vitellogenesis. Proteins from skeletal muscle are mobilized to address these demands leading 
to poor quality fillet. Increase in feeding levels to 74% satiation in rainbow trout during its sexual 
maturation partially prevents total loss by replacing mobilized endogenous proteins (CLEVELAND 
et al. 2012). Therefore, it is crucial to comprehend the role of feed in expression profiles of miRNA 
involved in growth. Findings from different feed experiments conducted in Atlantic cod, rainbow 
trout and Chinese perch corroborate differential miRNA expression governing myogenesis and 
skeletal muscle maintenance (MENNIGEN et al. 2013; ZHU et al. 2015a; ZHU et al. 2015b; 
BIZUAYEHU et al. 2016). Growth and development of Atlantic cod first fed with zooplankton is 
better compared to aquaculture feed. Eight differentially expressed miRNAs were identified 
among Atlantic cod fed with either zooplankton or aquaculture feeds whose target genes were 
involved in various metabolic and signaling pathways (BIZUAYEHU et al. 2016). This study 
indicated nutritional influence on genomic regulation that influenced growth and development. 
Refeeding juvenile Chinese perch after fasting for one week induced immediate changes in 
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miRNA expression (within 1 hour) whose targets are involved in resuming myogenesis after 
feeding (ZHU et al. 2015a; ZHU et al. 2015b). miR-1/miR-133 expression decreased during 
ontogeneic transition from edogenous to exogenous feed transition in rainbow trout leading to 
muscule hypertrophy demonstrating the importance of miRNA in all crucial stages (MENNIGEN et 
al. 2013). 
DNA METHYLATION 
Chemical modification of DNA bases was first reported in Tubercle bacillus and later in 
calf thymus DNA (JOHNSON AND COGHILL 1925; HOTCHKISS 1948). Further the importance of 
DNA methylation in transcriptional regulation of eukaryotic gene expression was reported by two 
simultaneous studies (HOLLIDAY AND PUGH 1975; RIGGS 1975). Since then, studies report the 
presence of such modifications in various organisms including prokaryotes, fungi, plants and 
animals. These modifications are post-synthetic, as the methyl group is added after the nucleotides 
are incorporated into the DNA. Methylation of bases is carried out by DNA methyltransferases 
(DNMT) and the methyl group is donated by S-Adenosyl methionine. DNA methylation in 
mammals is carried out by three DNMTs: DNMT1, DNMT3a, DNMT3b. However, 8 dnmt genes 
were identified in zebrafish dnmt1, dnmt2 while the rest were similar to the mammalian DNMT3 
(DONG et al. 2001; MHANNI et al. 2001; SHIMODA et al. 2005). DNMT1 is a maintenance 
methyltransferase mainly functioning in methylating hemi-methylated DNA strands during 
replication. DNMT3a and DNMT3b are de novo methyltransferases methylating nascent DNA or 
hemi-methylated DNA. De novo methyltransferases are essential for laying methylation marks 
during embryo implantation and early development (OKANO et al. 1998). The majority of base 
modifications in eukaryotes are on cytosines, while some of the unicellular organisms present 
methylation on adenosine (CUMMINGS et al. 1974; HATTMAN et al. 1978). Methyl group is added 
to the carbon at fifth position of cytosine resulting in 5mC. Until recently it was believed that 
methylation of cytosine is restricted to CpG dinucleotide. Advanced sequencing techniques as well 
as the ability to map sequences at base pair resolution disclosed non-CpG methylations. Non-CpG 
methylations are less frequent than CpG methylations and were seen in oocytes (mammalian) 
(TOMIZAWA et al. 2011b), adult brain (Asian Seabass) (XIE et al. 2012) and embryonic stem cells 
(mammalian) (RAMSAHOYE et al. 2000). In general DNA methylation is associated with 
transcriptional silencing with exceptions (BELL AND FELSENFELD 2000). Introduction of the methyl 
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group on cytosine affects the binding of proteins such as repressors, histones and hormone 
receptors to the DNA indicating regulation of gene expression (LIN AND RIGGS 1972; LIN et al. 
1976; KALLOS et al. 1978), by sterically preventing binding. The methylated regions act as binding 
sites for certain transcriptional repressors including MeCP2, MBD1 and MBD2 leading to closed 
chromatin (HENDRICH AND BIRD 1998).  
DNA methylation in fish species 
Vertebrate DNA is methylated at higher levels when compared to that of invertebrates 
(BIRD AND TAGGART 1980). Various studies report DNA methylation in fish under different 
physiological and environmental conditions. Vanyushin et al (VANYUSHIN et al. 1970) observed 
decreased DNA methylation in all tissues of salmon during its upstream migration.  Same group 
later ascertained a positive correlation between DNA methylation and GC content in marine fishes 
(VANYUSHIN et al. 1973). Exposure to various pollutants, toxins as well as habitat conditions 
influence DNA methylation patters in fish; exposure to oestradiol and cadmium resulted in 
hypermethylation in male gonad tissue of Gasterosteus aculeatus and Anguilla anguilla liver 
respectively (ANIAGU et al. 2008; PIERRON et al. 2014). Toxins like tributyltin and triphenyltin 
lead to hypomethylation in Sebastiscus marmoratus liver (WANG et al. 2009). Fish species with 
differences in habitat temperatures exhibit differences in DNA methylation. Polar fishes are 
hypermethylated when compared to tropical and temperate species (VARRIALE AND BERNARDI 
2006). Similar studies to understand the role of DNA methylation contributing to the physiological 
differences among hatchery reared and wild species of Oncorhynchus mykiss showed no 
significant differences in global DNA methylation with differences in specific sites (BLOUIN et al. 
2010). Differences in methylation patterns were also observed in species with differences in 
migration ability (BAERWALD et al. 2016), maturation pattern (MORÁN AND PÉREZ-FIGUEROA 
2011) and during metamorphosis (COVELO-SOTO et al. 2015). Sex reversal as an effect of 
environmental factors such as temperature is observed in various species including fish (DEVLIN 
AND NAGAHAMA 2002). DNA methylation is proved to negatively regulate gene expression of 
aromatase (cyp 19a), methylation in the cyp19a promoter was reported in female fish exposed to 
elevated temperatures which is generally a trait of male fish (NAVARRO-MARTÍN et al. 2011). 
Additionally, the role of DNA methylation in sex determination in fish was established in various 
studies using Cynoglossus semilaevis (SHAO et al. 2014) and Paralichthys olivaceus (WEN et al. 
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2014; SI et al. 2016). Also, evidence for transgene and repetitive sequence methylation was 
established in fish (WINN et al. 1995; KATO 1996). Collectively these studies indicate the important 
role of DNA methylation in fine tuning of gene expression in response to various physiological 
and environmental factors. 
DNA methylation during skeletal myogenesis 
Studies in humans confirmed the regulatory role of DNA methylation during myogenesis; 
including activation of muscle precursor cells, proliferation and differentiation. Comparative 
studies to understand the methylation landscape among myogenic differentiating cells and mature 
skeletal muscle suggested loss of methylation in mature fibers. Differentiating cells exhibit 
approximately 90% higher methylation rates when compared to mature myofibers (CARRIÓ et al. 
2015). Differential expression of enzymes involved in DNA methylation was observed in stage 
specific manner, Dnmt1 was upregulated during activation and downregulated during 
differentiation. Reduced expression of de novo methyltransferases Dnmt3a and demethylating 
enzymes Tet1, Tet2 and Tet3 during muscle precursor cell activation was reported while Dnmt3b 
remained unchanged (LIU et al. 1996; PALLAFACCHINA et al. 2010; LIU et al. 2013; RYALL et al. 
2015). The role of DNA methylation in cell fate commitment and in progression of myogenesis 
was supported by various studies using 5-azacytidine and antisense RNA against DNMT1 
(CONSTANTINIDES et al. 1977; SZYF et al. 1992). Proliferating myoblasts exposed to 5-azacytidine 
exhibited increased expression of myogenic genes including myogenin. This indicated a functional 
role of DNA methylation in allowing binding of myogenic transcription factors to their target 
genes promoting differentiation (SCARPA et al. 1996). Hyper and hypomethylation of various 
myogenic regulatory factors and genes involved in the process of myogenesis and their importance 
were reported in various studies listed in Table 1. Collectively these studies support the important 
role of DNA methylation in various stages on myogenesis. Although most of the studies represent 
CpG methylations, the importance of non-CpG methylations are yet to be identified. Additionally, 
technical methods used could not differentiate between methylated and hemi-methylated 
cytosines, hence studies understanding such differences are necessary to know the functional 
impact of DNA methylation in myogenesis. 
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Influence of estrogen on DNA methylation 
Increased expression of estrogen receptors  and  was observed in skeletal muscle of 
rainbow trout exposed to 17-estradiol within 24 hours of exposure (Fig 1). Supporting evidence 
from breast cancer and prostate cancer studies suggest a role for estradiol and its receptors  and 
 in regulation of gene repression through DNA methylation (ADJAKLY et al. 2014; JADHAV et al. 
2015; ARIAZI et al. 2017). Expression of DNA methylating enzymes DNMT1, DNMT3a and 
DNMT3b were reported to be influenced by sex steroid hormone in females during menstrual cycle 
(YAMAGATA et al. 2009). Exposure to estrogenic compounds led to hypomethylation of various 
genes in mice (LI et al. 1997; TANG et al. 2008; BROMER et al. 2010). Similarly, studies to 
understand the effect of 17-estradiol and soy phytoestrogens on DNA methylation in prostate 
cancer cells also showed decreased DNA methylation (ADJAKLY et al. 2014). Conversely, our 
studies indicate an increase in DNA methylation of myogenic differentiation factor MyoD1 
(KOGANTI et al. 2017b) in exon 1. Mostly decreased methylations reported in mice and cancer cell 
lines under the influence of E2 are CpG while increased methylations observed in skeletal muscle 
of rainbow trout are CpH methylations. Availability and use of advanced sequencing techniques 
assisted in identification of these CpH methylations. In general, evidence suggest that gene 
expression is regulated by E2 and its receptors via DNA methylation. 
Previous studies strongly suggest E2 leads to an imbalance of protein turnover, but direct 
evidence for the role of miRNA and DNA methylation in rainbow trout skeletal muscle and their 
contribution for imbalance in protein turnover under the influence of E2 is limited. Hence 
determination of the role of these molecular mechanisms is necessary. The current study aims in 
understanding the effect of E2 in rainbow trout skeletal muscle by firstly, determining differential 
expression of miRNAs and regulation of their target genes involved in muscle metabolism; 







Figure 1. Relative gene expression of estrogen receptors. 
Expression measured at 24 hours and 72 hours post treatment represented as mean values ± SEM 




































Table 1. Role of DNA methylation on expression of myogenic regulatory factors 
 
 
Methylation status of genes involved in 
myogenesis 
Functional contribution of genes Reference 
Hypermethylation of Pax3 in myogenic 
cells and mature muscle fibers 
Pax3 necessary for migration and 
early lineage commitment 
(TSUMAGARI 
et al. 2013) 
Hypomethylation of a giant muscle 
associated protein Obscn in muscle and 
hypermethylated in the same sites in 
myoblasts and myotubes 
Important in the formation of 
skeletal muscle 
(TSUMAGARI 
et al. 2013) 
Hypomethylation of Myh7b in muscle Important because of its intronic 
microRNA miR499 in skeletal and 
cardiac muscle 
(TSUMAGARI 
et al. 2013) 
hypermethylation in promoter regions of 
genes involved in muscle contraction and 
other muscle processes 
Important during terminal 
differentiation 
(MIYATA et al. 
2015) 
Hypermethylation of ID4 and ZNF238 
binding sites 
Important for myotube formation (MIYATA et al. 
2015) 
Demethylation of myogenin promoter 
region in differentiated muscle cells 
which is hypermethylated in myoblasts 
and other non-myogenic cells 




Hypomethylation of Notch1 and its 
ligands Dll1 and Jag2 in skeletal lineage 
cells  
Notch signalling is necessary for 




Lack of methylation in distal enhancer of 
myogenic differentiation factor MyoD1 
Suffecient for gene expression 
during skeletal muscle 
development 
(BRUNK et al. 
1996) 
Hypermethylation of Myf5 enhancer 
region in embryonic stem cells which is 
completely demethylated in muscle 
lineage cells including myoblasts, 
myotubes, and skeletal muscle 
Myf5 necessary for muscle cell 
lineage 
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17-Estradiol (E2) is a steroid hormone that negatively affects muscle growth in rainbow 
trout, but the mechanism associated with this response is not fully understood. To better 
characterize the effects of E2 on muscle, we identified differentially regulated microRNAs 
(miRNAs) and muscle atrophy-related transcripts in juvenile rainbow trout exposed to E2. Small 
RNA-Seq analysis of E2-treated vs. control muscle identified 36 differentially expressed miRNAs 
including those known to be involved in myogenesis, cell cycle, apoptosis, and cell death. Some 
important myogenic miRNAs, such as miR-133 and miR-206, are upregulated while others like 
miR-145 and miR-499, are downregulated. Gene Ontology analysis of the target genes regulated 
by the miRNAs involved in atrophy and cell cycle progression indicates that E2 leads to expansion 
of the quiescent myogenic precursor cell population to address atrophying mature muscle in 






Skeletal muscle in rainbow trout accounts for more than 50% of the total weight and exhibits 
indeterminate growth unlike other vertebrates (MOMMSEN AND MOON 2001). Quiescent myogenic 
precursor cells (MPCs), destined to muscle cell lineage, lie underneath the basal lamina of muscle 
fibers and contribute to both hypertrophic and hyperplastic growth (MOMMSEN AND MOON 2001; 
JOHNSTON et al. 2011). Myogenesis is initiated by activation of MPCs that are further proliferated 
and differentiated to form a mature muscle fiber or fuse to the existing fibers. This process involves 
coordinated communication among signaling pathways, epigenetic and different myogenic 
regulatory factors. Among several factors that control muscle synthesis and maintenance, 
hormonal regulation plays a vital role. Fish muscle harbors many hormone receptors capable of 
transducing signals into the cells and eventually contributing to changes in muscle metabolism. 
One example of such receptors is estrogen receptors (ERs) which bind and are activated by 17-
estradiol (E2). Four isoforms of ERs belonging to two different subtypes, ERα and ERβ, are 
present in rainbow trout (NAGLER et al. 2007).  
17β-Estradiol production and release is greatly increased during sexual maturation 
(LUBZENS et al. 2010a) in rainbow trout, driving high energy demanding metabolic processes 
during the follicular growth phase of vitellogenesis, including synthesis of vitellogenin by liver 
(ANDERSON et al. 1996). Earlier studies in cod and Pacific salmon indicate an increase in water 
content in muscle causing reduction in muscle quality during spawning (LOVE 1960a; SALEM et 
al. 2010b; DAVIDSON et al. 2014; MANOR et al. 2015). Reduction in muscle growth during 
spawning in rainbow trout partially results from an increase in protein turnover (SALEM et al. 
2006a; CLEVELAND AND WEBER 2011b; CLEVELAND et al. 2012) stimulated by maturation-related 
signals such as E2 (CLEVELAND AND WEBER 2011b; CLEVELAND AND WEBER 2016b). Also, the 
GH/IGF axis plays a major role in myogenesis (GABILLARD AND RESCAN 2013). Increase in E2 
levels during ovarian development in salmonids corresponds with decrease in IGF-1 (TAYLOR et 
al. 2008) as well as disruption of the GH/IGF axis (HOLLOWAY AND LEATHERLAND 1997b; 
NORBECK AND SHERIDAN 2011a; HANSON et al. 2012; HANSON et al. 2014). Therefore, negative 
effects of E2 on muscle growth are partially a result of endocrine mechanisms regulating growth. 
Findings from a study with ovariectomized mice with estrogen implants showed reduced IGF-1 (a 
potent mediator of skeletal muscle growth) expression with an increase in myostatin, a negative 
regulator of muscle development (TSAI et al. 2007).  
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Myogenic regulatory factors (MRFs) have a predominant role in the regulation of myogenic 
development. Regulatory noncoding RNAs (long noncoding and small RNAs) pose an additional 
level of gene regulation in the same process. A recent study of long noncoding RNAs in rainbow 
trout showed their role in skeletal muscle differentiation (WANG et al. 2016). Additionally, the 
function of miRNAs in skeletal muscle development is well addressed in a number of previous 
studies in vertebrates (GÜLLER AND RUSSELL 2010; SOKOL 2012; HITACHI AND TSUCHIDA 2013; 
LUO et al. 2013; WANG 2013; SHENOY AND BLELLOCH 2014; ZHANG et al. 2014). Rainbow trout 
miRNA from various tissues were recently reported (JUANCHICH et al. 2016), and miRNA serve 
as important regulatory factors of energy metabolism in teleosts (MENNIGEN 2015). miRNAs are 
small 21-23 nucleotide molecules transcribed either independently or from the intronic regions of 
protein coding genes. The transcribed primary miRNA is processed by Drosha to a hairpin, which 
is transported to the cytoplasm and further processed into a mature miRNA by Dicer. The miRNAs 
are involved in post-transcriptional gene regulation by binding to the 3’UTR region of their target 
mRNAs and in blocking translational initiation resulting in decreased gene expression. 
Knockdown of the Dicer gene in mice demonstrated the importance of miRNAs in skeletal muscle 
development. Both embryonic and postnatal skeletal muscle development were affected in the 
absence of miRNAs causing hypoplasia and death (O’Rourke et al., 2007). Small RNAs are 
essential components in the network of skeletal muscle development with very specific functions 
in proliferation, differentiation and maturation of myosatellite cells. miR-1, miR-133, and miR-
206 are well studied muscle-specific miRNAs (CALLIS et al. 2007; MCCARTHY AND ESSER 2007; 
MCCARTHY 2008; YUASA et al. 2008; CHEN et al. 2010; TOWNLEY-TILSON et al. 2010). They 
work in coordination with the MRFs and control cell fate. miR-1 promotes skeletal muscle 
differentiation, while miR-133 regulates proliferation. Along with these myogenic miRNAs, 
several other miRNAs have been identified for their prominent roles in myogenesis. They not only 
control the expression of different MRFs (CHEN et al. 2006a) but also play a role in signaling 
pathways controlling muscle cell proliferation and differentiation (ZANOU AND GAILLY 2013a).  
The main goal of the present study was to profile differentially expressed miRNAs in 
rainbow trout skeletal muscle under the influence of E2 relative to normal muscle using next 
generation sequencing (Illumina). Thirty-six differentially expressed miRNAs including three 
novel miRNAs were identified using DESeq2 analysis. Known important myogenic miRNAs 
including miR-206, miR-145 and miR-499, and ubiquitously expressed miRNAs having a role in 
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myogenesis including miR-214, miR-181, miR-125b and let-7 family, were either up regulated or 
down regulated under the influence of E2. Target gene analysis followed by gene ontology (GO) 
term enrichment for their roles in molecular function and biological processes revealed their roles 
in cell cycle and apoptosis. Findings from this study suggest involvement the role of miRNAs and 
their regulation through E2 in myogenesis. Collectively, these observations assist in understanding 
the basic mechanisms regulating muscle growth and contribute to the development of markers 
associated with muscle quality and nutrient partitioning in rainbow trout.  
MATERIALS AND METHODS 
Experimental design 
Animal experiments were conducted at the USDA/ARS National Center for Cool and Cold 
Water Aquaculture (NCCCWA) in accordance with methods approved by the NCCCWA 
Institutional Animal Care and Use Committee, protocol #50. Prior to the study, fish were fed with 
a commercial feed (Finfish G, Zeigler Brothers, Inc, Gardners, PA) and reared according to 
standard operating procedures. Feed was withheld the day of hormone injection. Twenty all-
female, diploid, juvenile fish weighing approximately 40 g were randomly selected for each 
treatment from an in-house population. Hormonal treatments included intraperitoneal injections of 
E2 and or the delivery vehicle to serve as the control. E2 was resuspended at 10 g/L in ethanol 
and diluted to 2.5 g/l with vegetable oil. The control treatment contained an equal ratio of 
ethanol: vegetable oil.  Fish were anesthetized with tricaine methylsulphonate (MS-222, 100 mg/l), 
weighed, and received intraperitoneal injections of E2 or the vehicle (2.0 l/g body weight). 
Injected fish were divided between four tanks (10 fish per treatment per tank).  One tank per 
treatment was harvested 24 and 72 hours post-injection.  Skeletal muscle was collected, 
immediately frozen using liquid nitrogen, and stored at -80 °C until analysis. 
RNA isolation  
Total RNA was prepared from skeletal muscle samples of fish treated with E2 and controls 
at 24 and 72 hours (n = 6). Approximately 100 mg of tissue were homogenized in Trizol reagent 
(Invitrogen, Carlsbad, CA) using a bench-top homogenizer followed by DNase treatment and 
column purification of total RNA using a Direct-zol™ RNA MiniPrep kit following the 
manufacturer’s instructions (Zymo Research). The quantity and quality of the total RNA was 
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evaluated by measuring absorbance at 260 nm and 280 nm using a NanoDrop 1000 
Spectrophotometer (Thermo Scientific). Four biological replicates from each treatment were 
sequenced.   
miRNA sequencing and data analysis 
Small RNA sequencing was performed using services provided by LC Sciences (Houston, 
TX). Four samples from each group with the highest A260:A280 ratios were used for sequencing.  
The quality of total RNA was confirmed with RNA Integrity Numbers greater than 9.0 determined 
by an Agilent Technologies 2100 Bioanalyser. Nucleotide fractions (15-50) of small RNA was 
isolated from the total RNA using polyacrylamide gel and were ligated to the 3’ adapter followed 
by 5’ adapter (Illumina, San Diego, CA). The small RNA ligated to the adaptors was reverse 
transcribed to cDNA, PCR amplified and gel purified. The gel-extracted cDNA was used for 
library preparation, which was further used for cluster generation on Illumina’s Cluster Station 
before sequencing using Illumina GAIIx. Raw sequence data was obtained from image data using 
Illumina’s Sequencing Control Studio software version 2.8 (SCS v2.8) following real-time 
sequencing image analysis and base-calling by Illumina's Real-Time Analysis version 1.8.70 
(RTA v1.8.70). ACGT101-miR v4.2 (LC Sciences) pipeline was used to analyze sequenced data. 
Sequences with low Q scores, reads mapped to mRNA, RFam, Repbase and piRNA database were 
deleted and unique families were generated from identical sequences. These filtered unique 
sequences were then mapped to pre-miRNA and miRNA in miRBase or to the genome of rainbow 
trout to identify conserved miRNA following ACGT-101 User’s Manual. Unique or novel 
miRNAs were identified after the BLAST performed against Pisces miRNAs from miRbase 
database (release 19) and published miRNAs from rainbow trout (RAMACHANDRA et al. 2008b; 
SALEM et al. 2010c; MA et al. 2012; MA et al. 2015). The miRNAs that do not match any sequences 
in the specified databases and have the propensity of forming hairpin structure with the extended 
sequences at the mapped positions were classified as unique miRNAs. These unique miRNAs were 
further classified into different groups depending on the mappable reads to selected miRNAs in 
the miRbase. Details of the miRNAs and their respective groups are presented in Supplementary 
Table.1. Differentially expressed miRNAs were identified using statistical software R (Version 
3.2.2) package DESeq2. Two different groups were considered for paired analysis: 1) E2 treated 
group compared to the control group at 24 hours, and 2) E2 treated group compared to control 
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group at 72 hours. 
Quantitative real time PCR 
Validation of differentially expressed miRNAs was performed using quantitative real time 
PCR (qPCR) using RNA isolated from 6 biological replicates. Two μg of DNase treated total RNA 
were used in cDNA synthesis using miScript II (Qiagen, Valencia, CA). U6 was used as an 
endogenous control for normalization. miRNA-specific forward primers (Supplementary Table 1) 
and a universal reverse primer were used for qPCR. DNA melting curve analysis was performed 
to determine the specificity of the amplicons. Standard curves with 10-time serial dilutions of a 
pooled cDNA sample were generated to calculate the efficiency of qPCR. Five l of 1,024 times 
diluted cDNA was used with iQ™ SYBR® Green Supermix (Bio-Rad) and 300 nM of forward 
and reverse primer in a final volume of 25 l reaction. Cycle conditions were the same for all the 
primers except the annealing temperatures for different primers. Initial denaturation at 95 °C for 3 
minutes followed by a denaturation at 95 °C for 40 sec, annealing for 30 sec, extension at 72 °C 
for 30 seconds for 40 cycles and a final extension for 10 min at 72 °C.  Melt curve analysis was 
performed with an increase of 0.5 °C increase every cycle. Quantification cycle (Cq) values were 
used for quantification of expression using the log-linear equation of standard curve. Relative fold 
changes were calculated by setting the values of the controls to 1.0 and comparing the respective 
treatment groups. Statistical analysis was performed using Student’s t-test and those with a p-value 
< 0.05 were considered statistically significant.  
Relative quantification of target gene transcripts of respective miRNA was determined using 
qPCR and statistically analyzed following the protocol mentioned above. Gene specific primers 
used in the analysis are listed in Supplementary Table 2. 
Prediction of target genes 
The potential target genes for the differentially expressed miRNAs were predicted using 
miRanda and PITA algorithms. 3’UTR, 5’UTR and the coding regions were used for prediction 
of the targets from the protein coding gene database of rainbow trout. Target genes predicted by 
both algorithms were used for further analysis. 
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Gene ontology enrichment analysis 
R package GOstats (FALCON AND GENTLEMAN 2007) was used for gene ontology (GO) 
enrichment (ASHBURNER et al. 2000) of target genes for respective miRNA. The target genes of 
each miRNA were tested against a gene reference created using the rainbow trout transcriptome 
sequence . Gene ontologies with respect to molecular function and biological processes were 
identified. 
RESULTS 
miRNA profile in rainbow trout skeletal muscle 
The skeletal muscle samples used for sequencing are from E2 treated and control fish at two 
time points, 24 hours and 72 hours after injections. A total of 246,336,230 raw reads were 
generated from 16 samples sequenced (4 biological replicates of each treatment at respective time 
points), of which 73% are mapped to rainbow trout genome. The mapped reads were further 
grouped depending on their similarity to the selected miRNAs from miRbase. The reads mapped 
to the rainbow trout genome and miRbase were further grouped as known miRNAs accounting for 
about 35.8% of the mapped reads. About 34.4% of the mapped reads also map to mRNA, RFam 
and Repbase (Table 1). The size of the reads ranged from 17 to 24 nucleotides, majority being 
around the size of 22 to 23 (Fig. 1a) with Phred scores higher than 35 indicating 99.9% accuracy 
in sequencing read. 
Myogenic miRNAs including miR-1, miR-133a and miR-206 are among the top five 
abundantly expressed miRNAs. Other highly expressed miRNAs include miR-100-5p, let-7a-5p, 
mir-10b-5p and miR-199-5p (Fig. 1b and 1c). The number of unique reads identified account for 
1,401, which were further grouped into known and predicted miRNAs. Group 1a in (Fig.1d and 
Supplementary Table 2) represents known miRNAs in rainbow trout, accounting for 
approximately 24 % of the total unique miRNAs. The novel miRNAs accounts for about 27 % and 
are represented as Group 4a. The other major groups are pre-miRs mapped to Pisces but not to the 
rainbow trout genome (Group 3b).  An incomplete rainbow trout genome sequence likely prevents 
mapping ability. 
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Differentially expressed miRNAs  
DESeq2 analysis indicated 36 differentially expressed miRNAs between E2 treated and 
control fish at 24 hours and one differentially expressed miRNA at 72 hours, all with an adjusted 
p-value less than 0.05. The log2 fold change ranged from -2.2 to 1.99, with 14 miRNAs 
downregulated and 22 upregulated. Supplementary Figure 1 is a Volcano plot representing all 
identified miRNAs. Red dots represent differentially expressed miRNAs (adjusted P-Value < 0.05) 
identified by DESeq2 and blue dots represent those with a log2 fold change of ± 1.5.  
Three of the differentially expressed miRNAs at 24 hours are novel miRNAs, including two 
that were identified in rainbow trout eggs previously (MA et al. 2012). Further analysis was 
performed with the differentially expressed miRNA at 24 hours. Pre-miRNA sequences were 
obtained and the 36 differentially expressed miRNAs were classified into 19 families using 
miRClassify. Details of the differentially expressed miRNAs (Table 2) including their families and 
precursor coordinates are presented (Supplementary Table 3). A clustered heatmap (Fig. 2) was 
generated for the differentially expressed miRNAs using R showing a significant difference in the 
expression between the E2 treated and control samples. 
Validation of differentially expressed miRNAs   
The sequencing data was verified using qPCR for the selected 5 miRNAs (omy-miR-214-
3p, omy-miR-499a-5p, omy-miR-23a-3p, omy-miR-145-5p, omy-miR-499-3p) for their role in 
myogenesis and related processes. The expression of these miRNAs were normalized using U6 
snRNA as an internal control. The expression of all 5 miRNAs was down regulated in rainbow 
trout skeletal muscles under the influence of E2 by RNA-Seq analysis (Fig.3). These results were 
consistent with qPCR results except for omy-miR-23a-3p, which showed no significant difference 
between the E2 treated and control samples in qPCR analysis (Fig. 3). 
Gene ontology enrichment analysis 
A significant number of enriched target genes with various molecular functions and 
biological processes were observed for both up and down regulated miRNAs with a P-value < 
0.01. R package GOstats was used for gene ontology enrichment analysis. Highly enriched genes 
involved in different biological processes include those that have significant roles in different 
signaling pathways, cell cycle, mitotic phase transition, quiescent stem cell regulation, 
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proliferation and differentiation, muscle cell chemotaxis, contraction and migration, programmed 
cell death, epigenetic regulation involving DNA methylation and histone modifications. Enriched 
GO terms in molecular function include phosphoprotein phosphatase activity, signal transduction, 
different histone and DNA modifying enzymes, DNA and nucleoside binding, cytoskeleton 
binding, transcription factor binding, helicase and proteases including ubiquitination and 
sumoylation activities. The top 10 enriched gene ontologies for biological processes and molecular 
function for both up-regulated and down-regulated miRNAs are presented in Table 3. 
Validation of miRNA target genes  
Regulation of proteolytic enzymes by Omy-miRNA-23a-3p 
ClustalW alignment of pre-miR-23a-3p sequences revealed a well-conserved mature miR-
23a-3p across different species (Fig. 4a). The miRNA was tested for binding with rainbow trout 
MuRF1 (HM357611.1) and fbxo32 (HM189693.1) sequences using RNA hybrid (KRÜGER AND 
REHMSMEIER 2006). The results showed that Omy-miR-23a-3p targets MuRF1 in the coding 
region, and fbxo32 at the 3’ untranslated region (Fig. 4b). qPCR analysis of the target genes 
MuRF1 and fbxo32 was performed and the results presented in Fig. 4c. The expression of fbxo32 
at 24 hours was increased in E2 treated samples with a fold change of 2.2 while no significant 
difference in the expression of MuRF1 in 24-hour samples. Additionally, the expression levels of 
both genes showed no significant difference in 72-hour samples. 
Gene ontology enrichment of Omy-miR-23a-3p also revealed its role in regulating 
mitochondrial outer membrane permeability implicating its role in apoptosis, innate immunity 
involving natural killer cells, mast cell activation, postsynaptic regulation, leucocyte and 
lymphocyte mediated immunity, muscle tissue morphogenesis, DNA mediated transposition, 
pyrimidine metabolism as well as DNA recombination and integration. Gene ontologies involved 
in mitochondrial membrane permeability and apoptosis are presented in Table 4. Thirteen target 
genes of this miRNA regulate mitochondrial organization, regulation and outer membrane 
permeabilization. These results suggest the role of mitochondrial permeability in muscle cells 
under the influence of E2. As the downstream effects of mitochondrial outer membrane 
permeability, the expression of caspases genes (caspase 3, caspase 8 and caspase 9) were 
determined by qPCR. The expression of the initiator caspase 9 and executor caspase 3 were higher 
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in E2 treated samples compared to the control samples at 24 hours (P-value < 0.05), while the 
expression of initiator caspase 8 did not show any difference (Fig. 4d). 
Cell cycle control by differentially expressed miRNAs 
GO enrichment analysis of the target genes of the differentially expressed miRNAs disclosed 
their roles in stem cell proliferation, maintenance and phase transition control in mitotic division 
(Table 5). These results led to a focus on the regulation of proliferation of myosatellite cells in 
treated samples in comparison to controls. Paired box transcription factor (Pax7) is a marker for 
quiescent stem cells and is necessary for the commitment of pluripotent cells to myogenic origin 
(SEALE et al. 2000), whereas MyoD and/or Myf5 are necessary for myosatellite cells to progress 
further to differentiate and eventually form a mature muscle cell. Expression profiles of myogenic 
regulatory factors were determined using qPCR. At 24 hours, the expression of Pax7 in treated 
samples is significantly higher in E2 treated samples compared to the controls opposing to the 
expression of the MRF’s MyoD. The expression levels of MyoD were decreased at 24 hours under 
the influence of E2. No significant differences were observed in the expression of Myf5 at the two 
time points (Fig. 5). 
Tissue distribution of novel miRNAs identified 
The pre-miRNA sequences of the novel miRNAs were obtained and stem loop structures 
were predicted using Mfold (ZUKER 2003) (Supplementary Fig. 2). This novel miRNA was named 
as omy-miR-nov-285-5p. qPCR results showed that this miRNA is present in all tissues analyzed 
with a difference in expression levels. The expression of this miRNA is the lowest in liver and 
highest in testis of the tissues analyzed. Tissue specific relative expression of this miRNA with 
respect to liver is presented in Fig. 6. The top 10 predicted target genes of this miRNA are 
presented (Supplementary Table 4). 
DISCUSSION 
Myogenesis is a complex process involving a network of signaling pathways of epigenetic 
and myogenic regulatory factors. In salmonids, the impact of E2 during ovarian growth contributes 
to loss in muscle mass or reductions in muscle growth (SALEM et al. 2006a; CLEVELAND AND 
WEBER 2011b; CLEVELAND AND WEBER 2015) unlike rodent, bovine and porcine species in which 
E2 has anabolic effects (REHFELDT et al. 2009a; KAMANGA-SOLLO et al. 2010a). Understanding 
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these differences contributing to muscle loss has been an area of emphasis in rainbow trout 
aquaculture. Noncoding RNAs and post-transcriptional control of miRNA sets an additional layer 
of control over gene expression. The importance of miRNAs in myosatellite cell maintenance 
(CHEUNG et al. 2012; CRIST et al. 2012), proliferation (GAMMELL 2007; HUANG et al. 2012b; 
SHENOY AND BLELLOCH 2014) and differentiation (NAKAJIMA et al. 2006; LIU et al. 2010; GAGAN 
et al. 2011) are well studied in different physiological and disease states of muscle (CHEN et al. 
2009; ROOIJ et al. 2009; GAMBARDELLA et al. 2010; NIELSEN et al. 2010; GOLJANEK-WHYSALL et 
al. 2012; KORNFELD et al. 2012; LIU et al. 2012; ROSALES et al. 2013; KIM et al. 2014). The roles 
of miRNAs during different metabolic states of muscle including apoptosis (GAMMELL 2007; 
HIRAI et al. 2010; WADA et al. 2011; HUDSON et al. 2014) and hypertrophy (MCCARTHY AND 
ESSER 2007; HITACHI AND TSUCHIDA 2013; JAVED et al. 2014) have also been established. 
Contribution of miRNAs in regulating different signaling pathways (GRANJON et al. 2009; WADA 
et al. 2011; HITACHI AND TSUCHIDA 2013; LUO et al. 2013) involved in myogenesis demonstrates 
their diverse roles in any living cell. Besides these prominent roles, miRNA also regulate different 
myogenic regulatory factors (MRFs) and are in turn regulated by different MRFs (NAGUIBNEVA 
et al. 2006; RAO et al. 2006; SWEETMAN et al. 2008; HIRAI et al. 2010; GAGAN et al. 2012).  
Previous reports in humans, rodents, and zebrafish indicate E2 influenced the expression of 
several miRNAs, including miR-125b, miR-145, miR-17-5p, miR-196b, let-7h, miR-206, miR-
20a and miR-21 (HOSSAIN et al. 2006; ADAMS et al. 2007; KOVALCHUK et al. 2007; SCOTT et al. 
2007; COHEN et al. 2008; DAI et al. 2008; KONDO et al. 2008), which were also identified to be 
responsive to E2 treatment in rainbow trout in this study.  The expression of miRNA is reported 
to be also regulated by estrogen receptor alpha and estrogen receptors in turn regulating the 
expression of miRNAs (KLINGE 2009). Four miRNA were reported to reduce the stability and 
translation of ER; miR-221, miR-222(ZHAO et al. 2008), miR-22 (SUN et al. 2008) and miR-206 
(KONDO et al. 2008) negatively regulate the expression of ER, which in turn regulates the 
expression of miR-206 (KONDO et al. 2008). Conclusively, the data presented here indicate that 
E2 dependent regulation of miRNA in rainbow trout muscle is supported by numerous studies that 
identify a significant role of miRNA-related mechanisms in E2-induced responses across different 
tissue types. 
miR-206 is up regulated along with a down regulation of miR-145, miR-181, miR-214, miR-
125b-3p and miR-499 after 24 hours in E2 treated fish.  In this study, the miR-206 sequence lacks 
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the seed sequence which is conserved among other species. Therefore, additional studies are 
warranted to further analyze the functional role of this miRNA, however, in rats, fast muscle 
atrophy induced by denervation is also associated with increased miR-206 expression (LI et al. 
2016) . miR-499 is highly expressed in type I muscles, encoded by myosin genes and is thought to 
play a role in coordinating the expression of myosin heavy chain in slow muscle (VAN ROOIJ et al. 
2008; MCCARTHY et al. 2009; VAN ROOIJ et al. 2009). Studies in humans with miR-125b-3p in 
different cell lines established its essential role in proliferation of differentiated cells (LEE et al. 
2005). Besides the expression of MyoD and myogenin, myosatellite cell differentiation also 
corresponds to the activation of miR-214 (JUAN et al. 2009), and the significance of miR-214 is 
confirmed by embryonic lethality and severe defects in muscle development in mice functional 
knockout studies (WATANABE et al. 2008).  Additionally miR-214 regulates IRS/AKT/PI3K 
pathway in C2C12 myocytes (HONARDOOST et al. 2015), and this also supports a role of miR-214 
in the process of differentiation. In the present study, miR-214 is down regulated in fish 24 hours 
after injection with E2, suggesting that this mechanism is involved with negative effects of E2 on 
myogenesis in rainbow trout. An additional miRNA down regulated by E2 was miR-145, which 
can regulate the PI3K pathway in humans (ROSALES et al. 2013),  and targets different factors 
involved in proliferation (MARTINEZ AND GREGORY 2010), including OCT4, SOX2 and KLF4 (XU 
et al. 2009), and its loss in smooth muscles resulted in increased proliferation with reduced 
differentiation (ZHANG 2009). Also down regulated by E2 in rainbow trout was miR-181a-3p, a 
miRNA known to regulate Nanog expression in humans (MINTZ et al. 2012), a protein that 
promotes myoblast pluripotency and reduces differentiation in C2C12 cells (LANG et al. 2009).  
Another important cluster of miRNA with a role in the cell cycle is the miR-17 cluster, of which 
miR-17 and miR-20a control c-Myc mediated cell proliferation in humans through reduction in 
E2F1 expression (O'DONNELL et al. 2005). In our study, these two miRNAs exhibited an E2-
induced expression increase, suggesting this mechanism may also be important for E2-induced 
reductions in muscle growth in rainbow trout.  Nearly all of the aforementioned findings occurred 
in mammals, most of which were human, and a functional role of these miRNAs in myogenesis 
cannot be assumed to be conserved between mammals and teleosts like rainbow trout. However, 
given these previous studies we can speculate that these miRNAs-related mechanisms that are 
regulated by E2 may be involved with the myogenic response, and additional studies can more 
clearly elucidate these candidate mechanisms. 
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An E2-induced increase in Pax7 expression occurred after 24 hours of E2 treatment.  In 
mammals, Pax7 is a marker of quiescent myogenic stem cells, however in indeterminate growing 
species like rainbow trout and Atlantic salmon, expression of Pax7 continues in differentiating 
myotubes in culture, potentially reflecting a population of self-renewing MPCs (BOWER AND 
JOHNSTON 2010; SEILIEZ et al. 2015).  Therefore, increased Pax7 expression during E2 treatment 
may represent reduced differentiation rates and/or an increased rate of MPC self-renewal. 
However, coordinated down-regulation of MyoD by E2 is suggestive of reductions in cell 
differentiation. Interestingly, in mammals, miR-206 directly down-regulates Pax7 expression 
during cell differentiation by binding to its 3’ untranslated region (DEY et al. 2011).  However, in 
the current study, the expression of both miR-206 and Pax7 was increased by E2 treatment, 
suggesting this interaction may not be conserved across species.  Indeed, the aforemention absence 
of the miR-206 seed sequence in rainbow trout supports this concept.  
Previous studies conducted by Cleveland et al., in rainbow trout, demonstrate that E2 
increases muscle catabolism, partially through elevations in protein degradation via up regulation 
of components of the ubiquitin-proteasome and autophagic-lysosome systems (CLEVELAND AND 
WEBER 2011b; CLEVELAND AND WEBER 2015; CLEVELAND AND WEBER 2016b). Part of the E2 
response is increased expression of E3 ubiquitin ligases, including muscle-specific atrophy gene 
Fbxo32/atrogin-1 and decreased expression of Omy-miR-23a-3p as shown in this study. It has 
been demonstrated in mice and C2C12 myocytes that miR-23a exhibits translational suppression 
by binding to the 3’ untranslated regions of Fbxo32 (WADA et al. 2011; HUDSON et al. 2014), 
subsequently reducing protein expression.  Therefore, the E2-induced reduction in Omy-miR-23a-
3p likely contributes to elevated Fbxo32 expression and increased proteolytic capacity in rainbow 
trout, suggesting a conserved mechanism.  Further contributing to muscle catabolism may be 
increases in mitochondrial outer membrane permeability (MOMP), the integrity of which is 
maintained by Omy-miR-23a-3p (TAIT AND GREEN 2010) . Therefore, E2-induced reductions in 
miR-23a-3p may increase MOMP, a mechanism associated with caspase-induced apoptosis (TAIT 
AND GREEN 2010), which themselves were affected by E2 treatment in rainbow trout.   
The identified novel miRNA, omy-miR-nov-285-5p, belongs to the miRNA family miR-
7911 with an accuracy of 72.74% (ZOU et al. 2014). miRNAs belonging to same family imply that 
they have similar sequence or structural configuration, hence similar function (KACZKOWSKI et al. 
2009). Studies in insects showed that miR-7911c-5p is expressed in immature testis and targets 
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the chromobox protein which is involved in chromosomal DNA packaging (TARIQ et al. 2016). 
Novel miRNA expressed in skeletal muscle after E2 exposure belongs to the same family with the 
probable function of chromatin remodeling. 
These findings suggest that E2 can affect processes of myogenesis and muscle growth, 
partially through regulation of miRNA-related mechanisms even within 24 hours of exposure in 
rainbow trout skeletal muscle. Figure 7 shows the proposed model highlighting the effects of E2 
in muscle cells. Omy-miR-23a-3p, a major regulator of muscle atrophy (HUDSON et al. 2014) is 
down regulated by E2. Hudson et al. also demonstrated the exosomal transport of miR-23a from 
the cell. This reduction in cellular levels of miR-23a resulted in increased expression of atrophic 
genes leading to cell death and atrophy. It is possible that increased cell death triggers the 
replacement of myogenic cells, which explains significant expression of MPC specific myogenic 
regulatory factor Pax7 in support to studies in zebrafish (FROEHLICH et al. 2013b). It is possible 
that E2 contributes to quiescent cell proliferation rather than differentiation, while the mature 
myotubes are prone to atrophy or cell death after 24 hours of treatment. Further emphasis on the 
increase of caspases and their effects should be considered to understand their potential role as 
protein degrading enzymes or regulators of cell division in the presence of E2.   
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Figure 1. miRNA profile of skeletal muscle from control and E2 treated sample. 
(A) Length distribution of all miRNA sequenced, major percentage of miRNA are of sizes 22 and 
23 nucleotides. (B and C) Abundantly expressed five miRNAs in control and treatment samples at 






Figure 2. Heat map showing differential expression of miRNAs.  
Statistically significant miRNAs after 24 hours of treatment. C4, C6, C7, C8 represent control 




Figure 3. Validation of miRNA sequencing results. 
Log2 fold change of E2 samples compared to control from sequencing and qPCR. Results are 






Figure 4. Omy-miR-23a-3p and its target genes. 
(A) ClustalW alignment of miR-23a primary transcript from selected species. (B) Putative duplex 
between the miRNA and its target genes MuRF1 (coding region) and Fbxo32 (3’UTR). (C and D) 
Relative expression of atrophic genes and caspases in control and E2 treated samples after 24 and 





Figure 5. Expression of myogenic regulatory factors (MRFs) defining cell cycle. 
Relative gene expression of MRFs in control and E2 treated samples after 24 and 72 hours, 



































Figure 6. Novel miRNA, omy-miR-nov-285-5p. 





Figure 7. Prospective response to E2. 
E2 and estrogen receptors could result in exosomal packaging of omy-miR-23a-3p, resulting in 
decrease in miRNA in the cell thus resulting in high expression of its target gene Atrogin-1/Fbxo32 
and increased mitochondrial outer membrane permeability further leading to increased caspases 
3a and 9. Fbxo32 drives the cell to atrophy while caspases to apoptotic damage. 
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TABLES 
Table 1. Summary of miRNA sequencing data. 
Reads obtained from E2 treated and control skeletal muscle samples at 24 and 72 hours. 
 Number of 
reads 
% of mappable 
reads 
Total mappable reads 181,005,496 100% 
Known miRNA 64,697,879 35.8% 
Predicted miRNA 37,264,799 20.6% 
Mapped to mRNA 28,508,740 15.8% 
Mapped to other RNAs (RFam: rRNA, tRNA, 
snRNA, snoRNA and others) 
32,206,146 17.8% 
Mapped to Repbase 1,402,438 0.8% 
Nohit 24,583,755 13.6% 
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Table 2. Differentially expressed miRNAs. 
Listed are the adjusted p-values < 0.05, their respective sequence and log2 fold change 
miRNA Name Sequence Log2Fold Change P-Value P-Adjusted 
omy-489-5p UGGUCGUAUGUAUGACGUCAUU -1.13 0.0032 0.0435 
omy-let-7a-5p-1 UGAGGUAGUAGGUUGU/GAUAGUUU/GU 1.33 0.0011 0.0206 
omy-let-7d-5p UGAGGUAGUUGGUUGUAUGGUU 0.69 0.0033 0.0435 
omy-let-7g-5p UGAGGUAGUAGUUUGUAUAGUU 0.46 0.0035 0.0444 
omy-let-7h-5p UGAGGUAGUAAGUUGUGUUGUU 0.69 0.0000 0.0008 
omy-let-7i-5p UGAGGUAGUAGUUUGUGCUGUU 0.79 0.0000 0.0009 
omy-let-7j-5p UGAGGUAGUUGUUUGUACAGUU 0.58 0.0002 0.0044 
omy-miR-125b-1-3p ACGGGUUAGGCUCUCGGGAGCU -0.99 0.0002 0.0044 
omy-miR-130a-3p CAGUGCAACAAUGAAAGGGCA 0.96 <0.0001 0.0000 
omy-mir-133a-2-3p UCAACUGUUGAAUGGAUU 1.16 0.0016 0.0299 
omy-miR-133a-5p AGCUGGUAAAAUGGAACCAAAU 0.72 0.0021 0.0333 
omy-miR-145-3p GGAUUCCUGGAAAUACUGUUCU -0.60 0.0017 0.0300 
omy-miR-145-5p GUCCAGUUUUCCCAGGAAUCCCU -0.85 <0.0001 0.0016 
omy-miR-17-5p CAAAGUGCUUACAGUGCAGGUA 0.62 <0.0001 0.0009 
omy-miR-181a*-3p ACCAUCGACCGUUGACUGUGCC -0.57 0.0001 0.0031 
omy-mir-193-5p-1 UGGGUCUUUGUUGGCAAGGUGA 1.99 <0.0001 0.0008 
omy-miR-193-5p-2 CGGGAUCUUGUGGGCGAGAUGA 1.25 0.0001 0.0039 
omy-mir-193-5p-3 UGGGUCUUUGCGGGCAAGGUGA 1.26 0.0004 0.0088 
omy-miR-196b-5p UAGGUAGUUUCAAGUUGUUGGG 1.21 <0.0001 0.0016 
omy-miR-206-3p GUAAGGAAGUGUGUGGA 1.60 0.0002 0.0044 
omy-miR-20a-5p UAAAGUGCUUAUAGUGCAGGUAG 1.35 <0.0001 0.0006 
omy-miR-21-5p UAGCUUAUCAGACUGGUGUUGGA 0.97 <0.0001 0.0018 
omy-miR-214-3p ACAGCAGGCACAGACAGGCAGU -0.58 0.0039 0.0471 
 57 
omy-miR-23a-3p AUCACAUUGCCAGGGAUUUCC -0.57 <0.0001 0.0004 
omy-miR-26b-5p UUCAAGUAAUCCAGGAUAGG 0.44 0.0021 0.0333 
omy-mir-338-5p AACAACAUCCUGGUGCUGCCUGAGU -0.71 0.0006 0.0134 
omy-miR-365-5p AGGGACUUUUAGGGGCAGCUGUG 1.09 0.0008 0.0154 
omy-miR-499-3p AACAUCACUUUAAGUCUG/CUGCU -2.09 0.0001 0.0019 
omy-miR-499-5p UUAAGACUUA/GCAGUGAUGUUUCGGU -1.98 0.0001 0.0040 
omy-miR-499a-5p UUAAGACUUGUAGUGAUGUUU -1.79 0.0006 0.0125 
omy-miR-551-3p GCGACCCAUCCUUGGUUUCUGU 0.67 0.0033 0.0435 
omy-miR-93a-5p AAAAGUGCUGUUUGUGCAGGUAG 0.95 <0.0001 0.0001 
omy-miR-nov-101-3p GCGACCCACUCAUGAUUUCAGA -1.59 0.0022 0.0335 
omy-miR-nov-285-5p GCAGUGGUUGUCGUAAUAGGUUC -2.25 <0.0001 <0.0001 
omy-let-7g-3p CUGUACAAGCCACUGCCUUGCU -0.82 0.0032 0.0435 
omy-nov-miR-29b-2-
p5 
GCUGGUUUCAGGUGGUGACUUAGA 1.33 0.0036 0.0444 
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Table 3. Enriched target genes of differentially expressed miRNAs. 
The target genes involved in different biological processes and molecular functions are listed. 
 
Top 10 enriched gene ontologies (molecular function) 
Up-Regulated miRNA 
GOMFID P-value Count Size GO Term 
GO:0004721 4.69E-20 50 482 Phosphoprotein phosphatase activity 
Top 10 enriched gene ontologies (biological processes) 
Up-Regulated miRNA 
GOBPID P-value Count Size GO Term 
GO:0006310 1.41E-12 49 1311 DNA recombination 
GO:0006313 1.27E-12 46 1169 Transposition, DNA-mediated 
GO:0016311 5.29E-16 55 741 Dephosphorylation 
GO:0030041 1.04E-11 20 237 Actin filament polymerization 
GO:0030838 4.02E-13 20 199 Positive regulation of actin filament 
polymerization 
GO:0031334 7.04E-13 20 205 Positive regulation of protein complex 
assembly 
GO:0032196 1.39E-12 46 1172 Transposition 
GO:0032273 4.42E-13 20 200 Positive regulation of protein 
polymerization 
GO:0045010 1.98E-14 20 170 Actin nucleation 
GO:0051495 2.86E-12 20 221 Positive regulation of cytoskeleton 
organization 
Down-Regulated miRNA 
GOBPID P-value Count Size GO Term 
GO:0006259 7.32E-25 144 2158 DNA metabolic process 
GO:0006310 2.95E-35 124 1311 DNA recombination 
GO:0006313 3.07E-38 121 1169 Transposition, DNA-mediated 
GO:0015074 2.87E-35 122 1272 DNA integration 
GO:0032196 3.96E-38 121 1172 Transposition 
GO:0055085 6.40E-12 263 2461 Transmembrane transport 
GO:0044710 2.82E-11 285 7574 Single-organism metabolic process 
GO:0006811 1.01E-10 247 2339 Ion transport 
GO:0044765 7.25E-10 397 4216 Single-organism transport 
GO:0007186 9.75E-10 170 1506 G-protein coupled receptor signaling 
pathway 
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GO:0004721 3.59E-16 55 482 Phosphoprotein phosphatase activity 
GO:0004803 3.38E-12 46 1169 Transposase activity 
GO:0005217 2.90E-12 13 56 Intracellular ligand-gated ion channel 
activity 
GO:0015278 2.26E-12 13 55 Calcium-release channel activity 
GO:0016788 1.59E-16 83 1419 Hydrolase activity, acting on ester 
bonds 
GO:0016791 1.28E-18 55 626 Phosphatase activity 
GO:0042578 1.03E-18 67 897 Phosphoric ester hydrolase activity 
GO:0005220 3.59E-10 8 20 Inositol 1,4,5-trisphosphate-sensitive 
calcium-release channel activity 
Down-Regulated miRNA 
GOMFID P-value Count Size GO Term 
GO:0003677 3.25E-15 194 4260 DNA binding 
GO:0004803 6.88E-39 121 1169 Transposase activity 
GO:0004872 5.55E-13 257 2391 Receptor activity 
GO:0004888 3.49E-13 211 1851 Transmembrane signaling receptor 
activity 
GO:0004930 9.98E-15 148 1109 G-protein coupled receptor activity 
GO:0019706 2.89E-12 16 49 Protein-cystein S-palmitoyltransferase 
activity 
GO:0019707 2.89E-12 16 49 Protein-cysteine S-acyltransferase 
activity 
GO:0022857 1.16E-12 238 2185 Transmembrane transporter activity 
GO:0038023 1.72E-12 231 2112 Signaling receptor activity 






Table 4. Target genes of omy-miR-23a-3p. 
Gene ontologies and p-values of target genes (predicted) of omy-miR-23a-3p involved in 
mitochondrial membrane permeability and apoptosis. 
Target gene ontologies of omy-miR-23a-3p regulating mitochondrial permeability and 
apoptosis 
GOBPID P-value Count Size GO Term 
GO:1901029 0.0001 2 2 Negative regulation of mitochondrial outer 
membrane permeabilization involved in 
apoptotic signaling pathway 
GO:0010823 0.0010 2 6 Negative regulation of mitochondrion 
organization 
GO:1901028 0.0024 2 9 Regulation of mitochondrial outer 
membrane permeabilization involved in 
apoptotic signaling pathway 
GO:0008637 0.0041 3 39 Apoptotic mitochondrial changes 
GO:0097345 0.0058 2 14 Mitochondrial outer membrane 
permeabilization 
GO:0035794 0.0067 2 15 Positive regulation of mitochondrial 
membrane permeability 
GO:1902110 0.0067 2 15 Positive regulation of mitochondrial 
membrane permeability involved in 
apoptotic process 
GO:1902686 0.0067 2 15 Mitochondrial outer membrane 
permeabilization involved in programmed 
cell death 
GO:1902108 0.0076 2 16 Regulation of mitochondrial membrane 
permeability involved in apoptotic process 
GO:0046902 0.0085 2 17 Regulation of mitochondrial membrane 
permeability 
GO:0090559 0.0085 2 17 Regulation of membrane permeability 
GO:0010821 0.0208 2 27 Regulation of mitochondrion organization 




Table 5. Target genes involved in cell cycle and myogenesis. 
Listed are the target genes of differentially expressed miRNAs that are involved in cell cycle and 
myogenesis 
Target genes related to Cell Cycle 
GOBPID P-value Count Size GO Term 
GO:0000083 0.0004 3 3 Regulation of transcription involved in 
G1/S transition of mitotic cell cycle 
GO:0000086 0.0029 6 42 G2/M transition of mitotic cell cycle 
GO:0000278 0.0096 28 553 Mitotic cell cycle 
GO:0007093 0.0050 7 54 Mitotic cell cycle checkpoint 
GO:0007346 0.0083 17 226 Regulation of mitotic cell cycle 
GO:0010971 0.0067 2 4 Positive regulation of G2/M transition of 
mitotic cell cycle 
GO:0022402 0.0015 35 650 Cell cycle process 
GO:0033260 0.0032 3 5 Nuclear cell cycle DNA replication 
GO:0033262 0.0011 2 2 Regulation of nuclear cell cycle DNA 
replication 
GO:0044770 0.0060 12 132 Cell cycle phase transition 
GO:0044772 0.0056 12 131 Mitotic cell cycle phase transition 
GO:0044786 0.0061 3 6 Cell cycle DNA replication 
GO:0044839 0.0029 6 42 Cell cycle G2/M phase transition 
GO:0051726 0.0054 51 497 Regulation of cell cycle 
GO:0071156 0.0004 3 5 Regulation of cell cycle arrest 
GO:0071157 0.0004 3 5 Negative regulation of cell cycle arrest 
GO:1901988 0.0082 7 59 Negative regulation of cell cycle phase 
transition 
GO:1901991 0.0082 7 59 Negative regulation of mitotic cell cycle 
phase transition 
GO:1902751 0.0067 2 4 Positive regulation of cell cycle G2/M phase 
transition 
GO:1903047 0.0027 24 409 Mitotic cell cycle process 
Target genes involved in proliferation of stem cells 
GOBPID P-value Count Size GO Term 
GO:0008283 0.0011 33 571 Cell proliferation 
GO:0042127 0.0002 28 415 Regulation of cell proliferation 
GO:0048144 0.0067 1 4 Fibroblast proliferation 
GO:0048145 0.0067 1 4 Regulation of fibroblast proliferation 
 62 
GO:0048146 0.0067 1 4 Positive regulation of fibroblast 
proliferation 
GO:0048145 0.0070 2 4 Regulation of fibroblast proliferation 
GO:0048146 0.0070 2 4 Positive regulation of fibroblast 
proliferation 
GO:0072089 0.0024 5 29 Stem cell proliferation 
GO:0072091 0.0004 4 17 Regulation of stem cell proliferation 
Target genes involved in the fate of MPC cells 
GOBPID P-value Count Size GO Term 
GO:0014717 0.0004 2 2 Regulation of satellite cell activation 
involved in skeletal muscle regeneration 
GO:0014719 0.0013 2 3 Skeletal muscle satellite cell activation 
GO:0014901 0.0004 2 2 Satellite cell activation involved in skeletal 
muscle regeneration 
GO:0033002 0.0062 3 33 Muscle cell proliferation 
GO:0042693 <0.0001 4 6 Muscle cell fate commitment 
GO:0043403 0.0013 2 3 Skeletal muscle tissue regeneration 
GO:0043416 0.0013 2 3 Regulation of skeletal muscle tissue 
regeneration 
GO:0051146 0.0099 18 250 Striated muscle cell differentiation 
GO:0014812 0.0011 2 9 Muscle cell migration 
GO:0042692 0.0051 18 281 Muscle cell differentiation 





Supplementary Figure 1. Volcano plot of miRNAs from sequencing analysis: miRNAs expressed 
above and below average were used for generating volcano plot. Differentially expressed miRNAs 










Supplementary Table 1. List of primers used for qPCR analysis  
Gene Name Primer 
efficiency 
Primer Name Sequence 
Muscle Ring-finger Protein 1 97% RT-Murf1F 5' CTGATTAGTGGCAAGGAGCTG 3' 
  
RT-Murf1R 5' GTAAGGTGCTCCATGTTCTCG 3' 
Atrogin-1 95% RT-Fbxo32F 5' TGCGATCAAATGGATTCAAA 3' 
  
RT-Fbxo32R 5' GATTGCATCATTTCCCCACT 3' 
Paired Box protein-7 104% RT-Pax7F  5' TACAGGTGTGGTTCAGCAACAG 3' 
  
RT-Pax7R 5' GCTGGTAGGTAGGTAGACTGG 3' 
MyoD 100% RT-MyoDF 5' CCTTACATGACCCAAACACCA 3' 
  
RT-MyoDR 5' GGCATGTTCTCTCCCCATAA 3' 
Myf5 127% RT-Myf5F 5' GACCTGTGTACCACGTATTGTG 3' 
  
RT-Myf5R 5' CCGAAATAGGAAGTCAAAGCGG 3' 
Caspase 3A 87% Casp3 5' TTTGGGAGTAGATTGCAGGG 3' 
   
5' TGCACATCCACGATTTGATT 3' 
Caspase 8 87% Casp8 5' CAGCATAGAGAAGCAAGGGG 3' 
   
5' TGACTGAGGGGAGCTGAGTT 3' 
Caspase 9 105% Casp9 5' TTCGAGACCTGGAGACTCGT 3' 
   
5' GCTATGCTGCCCTTTCTCAC 3' 
Omy-miR-nov-285-5p 100% omy-miR-nov-285-5p 5' GCAGTGGTTGTCGTAATAGGTTC 3' 
Omy-miR-214-3p 98% omy-miR-214-3p 5' ACAGCAGGCACAGACAGGCAGT 3' 
Omy-miR-23a-3p 77% omy-miR-23a-3p 5' ATCACATTGCCAGGGATTTCC 3' 
Omy-miR-145-5p 112% omy-miR-145-5p 5' GTCCAGTTTTCCCAGGAATCCCT 3' 
Omy-miR-499a-3p 101% omy-miR-499a-3p 5' AACATCACTTTAAGTCTCTGCT 3' 
Omy-miR-499-5p 73% omy-miR-499-5p 5' TTAAGACTTACAGTGATGTTTCGGT 3' 
Omy-miR-133a-5p NA omy-miR-133a-5p 5' AGCTGGTAAAATGGAACCAAAT 3' 
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Supplementary Table 2. miRNA groups based on the region mapped 
Group Mapped to 
Group 1a Mapped to rainbow trout genome 
Group 2a Mapped to known mirs of Pisces and rainbow trout genome, with hairpins 
Group 2b Mapped to known mirs of Pisces and rainbow trout genome, without hairpins 
Group 3a Mapped to mirs and miRs of Pisces but unmapped to rainbow trout genome 
Group 3b Mapped to mirs of Pisces but unmapped to rainbow trout genome 

















Supplementary Table 3. List of differentially expressed miRNA precursor coordinates, precursor sequence with their family name 






Consensus precursor sequence 








































































































































































































































































































































































































































































































































































Supplementary Table 4. Predicted target gene ontologies of novel miRNA Omy-miR-nov-285-5p 
Top 10 target genes of novel miRNA (biological processes) 
GOBPID P-value Count Size GO Term 
GO:0016042 1.17E-07 23 196 Lipid catabolic process 
GO:0060395 1.47E-07 10 36 SMAD protein signal transduction 
GO:0010862 1.13E-06 10 44 Positive regulation of pathway-restricted SMAD 
protein phosphorylation 
GO:0060393 1.42E-06 10 45 Regulation of pathway-restricted SMAD protein 
phosphorylation 
GO:0060389 1.76E-06 10 46 Pathway-restricted SMAD protein 
phosphorylation 
GO:0090100 1.50E-05 11 70 Positive regulation of transmembrane receptor 
protein serine/threonine kinase signaling pathway 
GO:0090116 3.42E-05 3 3 C-5 methylation of cytosine 
GO:1990009 3.42E-05 3 3 Retinal cell apoptotic process 
GO:0090092 8.81E-05 14 130 Regulation of transmembrane receptor protein 
serine/threonine kinase signaling pathway 
GO:0002934 0.000122 4 9 Desmosome organization 
Top 10 target genes of novel miRNA (molecular function) 
GO:0019706 2.89E-12 16 49 Protein-cysteine S-palmitoyltransferase activity 
GO:0019707 2.89E-12 16 49 Protein-cysteine S-acyltransferase activity 
GO:0004435 3.72E-11 19 84 Phosphatidylinositol phospholipase C activity 
GO:0016409 3.88E-11 16 57 Palmitoyltransferase activity 
GO:0004629 7.15E-11 19 87 Phospholipase C activity 
GO:0016417 2.62E-10 16 64 S-acyltransferase activity 
GO:0004620 1.90E-07 20 151 Phospholipase activity 
GO:0005160 4.48E-06 10 49 Transforming growth factor beta receptor binding 
GO:0016298 4.83E-06 20 185 Lipase activity 
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ABSTRACT 
 MyoD is an important myogenic transcription factor necessary for the differentiation of 
myogenic precursor cells (MPC) to form mature myotubes, a process essential for muscle growth. 
Epigenetic markers such as CpH methylation are known gene regulators that are important for the 
differentiation process. In this study, we investigated whether DNA methylation is a potential 
mechanism associated with the ability of 17β-estradiol (E2) to reduce MyoD gene expression and 
muscle growth in rainbow trout. Rainbow trout received a single intraperitoneal injection of E2 or 
the injection vehicle (control). Skeletal muscle was collected 24 hours post-injection and analyzed 
for DNA methylation within the MyoD gene and the expression of DNA methyltransferases was 
quantified. CpG islands of the MyoD gene were predicted using MethPrimer software and these 
regions were PCR amplified after bisulfite treatment and sequenced. The percent methylation of 
the targeted CpG did not differ between control and E2-treated fish. However, percent CpH 
methylation in MyoD exon 1 region was elevated with E2 treatment. Two of the methylated CpH 
sites were located in conserved transcription factor binding motifs, an estrogen response element 
(ERE) and a Myc binding site. Quantitative real time PCR analysis revealed a significant increase 
in expression of DNA methyltransferases, Dnmt3a and Dnmt3b, in E2-treated muscle, suggesting 
an increased genome methylation. Differential CpH methylation in the MyoD gene of control and 
E2-treated fish suggests an epigenetic mechanism through which E2 decreases MyoD gene 




DNA methylation is one of the epigenetic mechanisms regulating gene expression. 
Cytosines in DNA are methylated at C5 by DNA methyltransferases (Dnmt) to form 5-
methylcytosines. These modified bases interact with and recruit different proteins collectively 
involved in chromatin remodeling and regulation of gene expression (CHENG AND BLUMENTHAL 
2010). Even though the existence of this modification was identified immediately after the 
discovery of DNA as hereditary material (AVERY et al. 1944; MCCARTY AND AVERY 1946), its 
role in gene regulation and cell differentiation was not reported until later (HOLLIDAY AND PUGH 
1975; COMPERE AND PALMITER 1981). Dnmt1 is a maintenance methyltransferase, which functions 
during replication by adding a methyl group to cytosines of the new strand, whereas Dnmt3a and 
Dnmt3b are de novo methyltransferases, transferring methyl groups to un-methylated cytosines. 
Methylation of cytosines in the contexts of CpA, CpT, and CpC is known as CpH (non-CpG) 
methylation. It is mediated by Dnmt3a and Dnmt3b, and is also strongly correlated with CpG 
methylation in flanking regions (ARAND et al. 2012). The availability of whole genome sequencing 
techniques assisted in identification of CpH methylation in mammalian cells (LISTER et al. 2013). 
Epigenome and gene expression studies using various tissues from humans revealed tissue 
specificity of CpH methylation and its role in gene regulation (SCHULTZ et al. 2015).  
Skeletal muscle development and regeneration is the result of both hyperplastic and 
hypertrophic growth in fish, including rainbow trout (Oncorhynchus mykiss). Myogenic precursor 
cells (MPCs) proliferate and differentiate to form mature myotubes. These processes are regulated 
by different transcription factors including Pax7 and myogenic regulatory factors (MRFs). MRFs 
are basic helix loop helix transcription factors binding to the E-box motifs of DNA to regulate 
gene expression. MyoD and Myf5 are considered as primary MRFs that direct the differentiation 
of MPCs, of which MyoD is considered as a master regulator of muscle precursor cell 
differentiation. In rainbow trout, 17β-estradiol (E2) is a maturation-related signal that mediates 
reductions in muscle accretion during sexual maturation (NAZAR et al. 1991b; NORBECK AND 
SHERIDAN 2011b; CLEVELAND AND WEBER 2016a). We recently demonstrated that E2 treatment 
reduces the expression of MyoD gene in rainbow trout muscle, and this likely occurs independent 
of mechanisms directly involving miRNAs (KOGANTI et al. 2017a). Given the significance of 
DNA methylation as a significant regulator of gene expression, we investigated whether this 
mechanism is associated with transcriptional regulation of MyoD by E2 in rainbow trout muscle. 
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DNA bisulfite conversion and PCR of CpG rich regions of MyoD gene were performed using 
skeletal muscle samples from the previous study (KOGANTI et al. 2017a). Amplicons were 
sequenced using Illumina technology and differential methylations were analyzed. Our data 
showed that percent methylation of the CpG sites did not differ between control and E2-treated 
fish. However, percent CpH methylation in MyoD exon 1 region was elevated in E2-treated 
muscle. In addition, the expression of two DNA methyltransferases, Dnmt3a and Dnmt3b, was 
significantly increased in E2-treated muscle. These observations explain reduced expression of 
MyoD under the influence of estrogen, providing additional evidence for the role of gene body 
CpH methylation in maintenance of MPCs. 
MATERIALS AND METHODS 
Sample collection 
Skeletal muscle samples used in this study were from a previous study conducted at the 
USDA/ARS National Center for Cool and Cold Water Aquaculture (KOGANTI et al. 2017a). 
Briefly, ten juvenile rainbow trout (~40 g) were used for each group (treatment or control). They 
received intraperitoneal injections of E2 (5.0 g per g body weight) or the delivery vehicle 
(control). Skeletal muscle samples were collected 24 hours post-injection. Four samples from each 
group were randomly selected and used in this study. 
Screening of CpG islands in silico 
The coding sequence of MyoD was obtained from NCBI (accession number – Z46924.1), 
which was further used to obtain MyoD gene sequence from the recently published rainbow trout 
genome sequence. Methprimer software (http://www.urogene.org/methprimer/) was used to 
predict CpG islands and design bisulfite specific primers. Three separate regions with 9 CpG sites 
(upstream region), 14 CpG sites (exon1-region1) and 6 CpG sites (exon1-region2) were further 
chosen for amplification and sequencing. 
DNA isolation and bisulfite conversion 
DNA was isolated from E2-treated and control skeletal muscle samples (n = 4 per group) 
using Quick-DNATM Universal kit (Zymo Research) following the manufacturer’s protocol. The 
quantity and quality of the DNA was estimated using NanoDrop 1000 Spectrophotometer (Thermo 
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Scientific) by measuring absorbance at 260 nm and 280 nm. Bisulfite conversion of DNA (500 ng) 
was performed using EZ DNA Methylation–LightningTM kit from Zymo Research and converted 
DNA stored at -80 oC until further use. 
Bisulfite specific PCR and bisulfite amplicon sequencing 
Bisulfite-specific PCR was performed with 5 L of 1:50 diluted bisulfite-converted DNA 
in a 25-L reaction. Three regions with amplicon sizes 281 bp, 251 bp, and 185 bp were amplified 
using bisulfite specific primers (Table S1) following standard conditions: 95 oC for 5 min, 35 
cycles of 95 oC for 30 s, 55 oC for 30 s, 72 oC for 30 s with a final 72 oC extension for 7 min. PCR 
products were separated using agarose gel electrophoresis and eluted using QIA-Quick Gel 
Extraction kit (Qiagen) following manufacturer’s protocol. The concentration of DNA (PCR 
amplicon) in the final elution was determined using NanoDrop. Equal concentrations of PCR 
amplified DNA were pooled from each of the four replicates within a treatment to produce two 
samples (control and E2) for next generation sequencing (Mr. DNA, Shallowater, TX).  
Identification of differentially methylated regions 
The reads obtained from control and E2 treated samples were mapped to MyoD genomic 
sequence, sorted, and indexed before using them in Integrative Genome Viewer (ROBINSON et al. 
2011a) to identify differentially methylated regions. Percentage of cytosines methylated in control 
and E2 treated samples were calculated based on the number of unconverted cytosines relative to 
the number of reads. Chi-square tests were used to statistically determine the differentially 
methylated sites and those with a P-value < 0.01 and < 0.0001 are considered significant and highly 
significant, respectively.  
RNA isolation and quantitative real-time PCR (qPCR) 
Total RNA was isolated from approximately 100 mg skeletal muscle (n = 6 per treatment) 
using Trizol reagent (Invitrogen, Carlsbad, CA) and Direct-zolTM RNA MiniPrep kit following the 
manufacturer's instructions (Zymo Research). cDNA was synthesized from 2 g of DNase-treated 
total RNA using miScript II (Qiagen, Valencia, CA). qPCR was performed using gene specific 
primers, 5 L of 1:1,024 diluted cDNA and iQTM SYBR® Green Supermix (Bio-Rad) in a final 
volume of 25 L. Cycling conditions used were 95 oC for 3 min followed by a denaturation at 95 
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oC for 40 s, annealing at 58 oC for 30 s, extension at 72 oC for 30 s for 40 cycles and a final 
extension for 10 min at 72 oC followed by a melting curve analysis. -actin was used as an 
endogenous control for normalization. Efficiency of qPCR was calculated using a standard curve 
generated using a 10-time serial dilution of a pooled cDNA sample. Primers used for qPCR are 
listed in Table S1. The expression of DNA methyltransferases was expressed as relative fold 
changes, which were calculated by dividing the means of normalized gene expression values for 
the E2 treated samples by the means of normalized gene expression values for the control samples. 
Statistical analysis was performed using the Student’s t-test with significant differences indicated 
as P-value < 0.05. 
RESULTS  
 Three CpG rich regions were identified in the MyoD genomic sequence (Fig. S1). One of 
the regions is located -3308 to -3161 upstream of the translation start site, represented as upstream 
region. The second and third CpG rich regions are within the first exon, +14 to +186 represented 
as exon1-region1 and +256 to +340 represented as exon1-region2. More than 1,000 reads for each 
region were obtained through Illumina sequencing.  
 Methylation percentage of the 9 CpG sites in the upstream region ranged from 27% to 47% 
(no significant difference). Eleven of 14 CpG sites in exon1-region1 exhibited methylations; 
percent methylation of 3 sites was less than 50% while the remaining 8 sites ranged from 50% to 
97%. Four CpG sites are differentially methylated in exon1-region1, one showing higher 
percentage in control (50%) than E2 treated samples (4%) with a (P-value < 0.0001) while the 
others exhibiting 6%, 78% and 81% in control and 26%, 93% and 94% in E2 samples (P-value < 
0.01). All 6 CpG sites in exon1-region2 presented lower methylation levels (< 11%) with no 
significant difference in methylation levels. Heat map comparing methylation percentages of 
control and E2 treated samples of different regions are presented in Fig 1. None of the other CpG 
sites in three regions studied are differentially methylated. Details of percent methylation of CpG 
and CpH sites in three regions are presented in Table S2.  
 In addition to the CpG methylations, exon1-region1 exhibited unexpected differential 
methylation of CpH sites, with a higher methylation percentage in E2 versus control muscle (Fig. 
1b). Seven CpH sites in exon1-region1 presented methylation on both control and E2 treatment 
samples. Methylation percentage ranged from 0% to 38% in control and 0% to 97% in E2-treated 
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samples. Among the methylated CpH (mCpH) sites, CpA dinucleotides are predominant, followed 
by CpC and CpT. Five of the mCpH sites showed significant differential methylation with higher 
percentage of methylation in E2 samples than in controls. Comparison of highly methylated CpG 
and CpH sites in MyoD exon1-region1 across species using Clustal Omega revealed that most of 
the mCpH sites are well conserved. Sequence alignment of exon1-region1 with methylated 
cytosines are presented in Fig 1e. Comet software was used to find motif clusters and those motifs 
that overlap with mC are highlighted. Exon 1 of rainbow trout MyoD gene harbors one estrogen 
response element (ERE) and two Myc binding motifs (Fig. 1e). Both CpG and non-CpG 
methylations were observed within and neighboring ERE and Myc transcriptional elements. In the 
two Myc motifs, the first element showed methylation in a central CpG site and the second in a 
CpA upstream of the central CpG. Fifty percent of the central CpGs were methylated in control 
with 4% in E2 treated samples and 87% and 0% CpA methylations in E2 and control samples, 
respectively. Similarly, ERE also presented methylations in both CpG and CpH context, with 42% 
and 0% in control and 50% and 88% in E2 samples.  
 qPCR was performed to analyze the expression profiles of enzymes mediating DNA 
methylations. A 3.7-fold increase in the expression levels of Dnmt1, 2.6-fold increase in Dnmt3a, 
and 8-fold increase in Dnmt3b were detected in skeletal muscles 24 hours post E2 treatment. 
Relative gene expression of methyltransferases is presented in Fig 2.  
DISCUSSION 
Novel approaches involving next generation sequencing have been used to identify CpG 
rich regions in various studies (MASSER et al. 2015; AKAGI et al. 2016). Although E2 did not affect 
CpG methylation substantially, various studies have confirmed site-specific DNA methylation as 
a mechanism in regulating gene expression. CpG methylation in regulatory and promotor regions 
largely downregulate gene expression while most CpG methylations in the gene body enhance 
gene expression. For example, over expression of Dmnt1 in C2C12 myoblasts increased 
methylation of CpG islands across MyoD exon 1 and exon 2, elevated MyoD gene expression, and 
accelerated terminal differentiation (TAKAGI et al. 1995). Evidence of MyoD gene methylation in 
10T1/2 fibroblasts, adipocyte derivatives, and demethylation in myogenic derivatives was reported 
during treatment with the demethylating agent, 5-azacytidine, further supporting the role of DNA 
CpG methylation as a mechanism that regulates MyoD gene expression (JONES et al. 1990). 
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However, further investigation revealed that methylation of CpG islands around the MyoD 
promoter region occurs in 10T1/2 fibroblasts, but not in myogenic derivatives. Later Brunk et al. 
identified a distal enhancer region conserved in humans and mice that is methylated at all CpG 
sites in non-muscle cells, contrasting to myogenic cells (BRUNK et al. 1996). Collectively, these 
studies indicate the prominent role of DNA methylation in MyoD gene expression, although there 
are mechanistic differences between tissue types.  
Elevated CpH methylation in E2-treated samples suggests an effect of E2 on de novo 
methylation of MyoD in vivo. Existence of CpH methylation in gene exons and flanking regions 
has been previously reported (HAINES et al. 2001; KOUIDOU et al. 2005). In fact, myogenin, a 
second MRF, exhibits DNA methylation of both CpG and non-CpG elements in 5’ flanking 
regions, with demethylation of non-CpG elements occurring more rapidly than CpG elements 
(FUSO et al. 2010). In the present study, significant reduction of CpH methylation in control 
samples could represent demethylation activity and aid in differential MyoD expression. Studies 
from humans (TOMIZAWA et al. 2011a; ZILLER et al. 2011; GÓMEZ et al. 2015) and Drosophila 
(RAMSAHOYE et al. 2000) reported the presence of CpH methylations in pluripotent cells and 
oocytes, which were lost upon differentiation of cells or embryo formation. Previously, we 
reported reduced MyoD gene expression in rainbow trout skeletal muscle 24 hours after E2 
treatment (KOGANTI et al. 2017a). Collectively, these findings support E2 induced negative 
regulation of MyoD gene expression, partially via increased gene body CpH methylation.  
Transcriptional gene regulation is controlled by various regions including promoters, 
enhancers and repressors. These elements are often harbored in both exons and introns. ERE and 
Myc elements, which can regulate gene expression, were identified in exon1-region1 of MyoD. 
Supporting our findings is a positive transcriptional regulatory element that was reported within 
exon 1 of the mouse elastin gene (PIERCE et al. 2006) and a negative transcriptional regulatory 
element in an intron of the bovine elastin gene (MANOHAR AND ANWAR 1994). To regulate gene 
expression, ligand (E2) bound estrogen receptors bind to EREs (WALLACE 1985) and Myc family 
proteins bind to Myc elements. The presence of CpG and non-CpG methylations within and 
neighboring Myc and ERE transcriptional elements suggests probable interaction between these 
two mechanisms to regulate MyoD gene expression. Furthermore, differential CpH methylation 
by E2 introduces epigenetic modification as a mechanism through which it regulates MyoD 
expression. Supporting this concept are previous findings indicating that Myc protein binding is 
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negatively affected by methylation of the central CpG present in its motif GACCACGTGGTC 
(PRENDERGAST et al. 1991). Likewise, methylations observed in the current study might regulate 
Myc binding to regulate gene expression. Therefore, treatment-dependent methylation patterns in 
Myc motifs indicate their probable role in regulation of gene expression. Further studies to 
understand the effects of these methylations on Myc and ER binding are warranted. 
 DNA methyltransferases are enzymes responsible for the transfer of methyl group to 
cytosines. Given the role for Dnmt3 in de novo methylations, up-regulation of Dnmt3a and Dnmt3b 
in E2-treated samples is consistent with the observed increase in CpH methylation in exon1-
region1. Whole genome bisulfite sequencing would give better understanding of genome wide 
methylations and the epigenetic consequences of increased expression of Dnmt1 and Dnmt3a 
under the influence of E2. 
 Collectively, these observations expand our understanding of the effects of E2 on DNA 
methylation of the MyoD gene. The presence of both CpG and CpH methylations in the MyoD 
gene indicates DNA methylation is a regulator of MyoD expression in rainbow trout muscle. 
Furthermore, the E2-induced increase in CpH methylation in transcriptional regulatory regions of 
MyoD exon 1 suggests a mechanism through which MyoD expression is reduced in E2-treated fish.  
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Figure 1. Heat maps showing methylation of CpG and CpH sites in MyoD gene and 
alignment of MyoD exon1. 
(a) CpG sites in upstream region, (b) CpH sites in exon1-region1, (c) CpG sites in exon1-region1 
and (d) CpG sites in exon1-region2. Top row represents methylated sites from control samples and 
bottom row represents methylated sites from E2-treated samples. Differentially methylated sites 
with statistical significance were indicated *P < 0.01 and **P < 0.0001. Below each block is the 
position of methylated cytosines relative to translation start site ATG, A considered as position 
+1. (e) Alignment of the MyoD exon 1 region of selected species. Methylated CpG and CpH sites 
were shown in red and blue boxes, respectively, with percent methylation indicated (control, E2) 
in parenthesis above each box. ERE site is highlighted in yellow and Myc motifs are highlighted 





Figure 2. Relative expression of DNMTs. 
qPCR analysis of mRNA expression of Dnmt 1, Dnmt 3a and Dnmt 3b in E2 treated samples 
relative to control samples. Results are expressed as fold change ± SE (n = 6). *P < 0.05 and **P 

















































Supplementary Figure 1. Schematic map showing three CpG rich regions in MyoD gene. Upstream 
region: -3308 to -3161 upstream of the translation start site. Exon1-region1 and Exon1-region2: 
+14 to +186 and +256 to +340 in the first exon, respectively. 
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Supplementary Table 1. List of primers used for bisulfite specific PCR and qPCR.  
Gene /Gene Region Primer Name Sequence 
Primers used for bisulfite specific PCR 
MyoD-Upstream 
Region 
MyoD-Up-Methyl F 5' GGGGTTTAGGTTTATTGTTTGTTAG 3' 
  MyoD-Up-Methyl R 5' AAACTTATTCAAAACACATCATTTACC 3' 
MyoD-Exon1-Region1 MyoD-Exon1-R1 F 5' TAAGGTTGGTTTTGGAATTTGATAG 3' 
  MyoD-Exon1-R1 R 5' TTTACATACCCAAAAAAAACACCT 3' 
MyoD-Exon1-Region2 MyoD-Exon2-R1 F 5' GAGGTGTTTTTTTTGGGTATGTAAA 3' 
  MyoD-Exon2-R1 R 5' CATTTCTCAAAATCTCCACCTTAAA 3' 
   




DNMT1 F 5' CACCCTGACAAGAAGAATGGTC 3' 




DNMT3a F 5' GAGGACCATCACCACTCGCTC 3' 




DNMT3b F 5' CTGGATGTTCGAGAATGTGGTC 3' 




Supplementary Table 2.  Percent methylation of CpG and CpH sites in three regions of MyoD gene 









mCpG 33 29 5.41E-01 
mCpG 40 35 4.65E-01 
mCpG 27 30 6.38E-01 
mCpG 40 36 5.60E-01 
mCpG 40 34 3.80E-01 
mCpG 34 36 7.67E-01 
mCpG 47 40 3.18E-01 
mCpG 38 31 2.98E-01 
mCpG 40 40 1.00E+00 
Exon 1-Region 1 
mCpG 6 26 1.15E-04 
mCpG 31 30 8.78E-01 
mCpG 8 1 1.70E-02 
mCpG 50 4 2.36E-13 
mCpH 38 44 3.88E-01 
mCpG 50 45 4.79E-01 
mCpG 42 50 2.56E-01 
mCpH 0 88 4.76E-36 
mCpH 0 87 2.34E-35 
mCpH 1 97 5.32E-42 
mCpH 13 8 2.49E-01 
mCpG 78 93 2.59E-03 
mCpG 91 90 8.09E-01 
mCpH 13 0 1.92E-04 
mCpH 0 91 3.39E-38 
mCpG 81 94 5.44E-03 
mCpG 95 97 4.70E-01 
mCpG 92 89 4.69E-01 
Exon 1-Region 2 
mCpG 10 11 8.18E-01 
mCpG 10 7 4.47E-01 
mCpG 8 7 7.88E-01 
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mCpG 7 7 1.00E+00 
mCpG 6 7 7.74E-01 
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Cytosine methylation is one of the epigenetic mechanisms important in determining gene 
expression. Current understanding of the role of DNA methylation in regulating an imbalance of 
protein turn over in rainbow trout skeletal muscle exposed to 17-estradiol (E2) remains limited. 
Our previous study suggests a role for DNA methylation in muscle precursor cell differentiation. 
Therefore, we further investigated and characterized the whole genome methylation landscape in 
control and E2 treated samples, identifying differentially methylated regions (DMRs). Whole 
genome bisulfite sequencing was performed at single nucleotide resolution, and cytosine 
methylations in CG, CHG and CHH contexts were identified. A total of 43 million CG sites were 
identified in the trout genome, of which 304,000 sites were differentially methylated in E2 treated 
samples compared to the control. The difference in methylation between control and E2 treated 
samples was estimated, and those regions that are differentially methylated at  80% rate were 
documented for further analysis. About 818 differentially methylated regions were differentially 
methylated at  80% and 408 were further mapped to 208 protein coding genes. Gene ontology 
and KEGG pathways analysis of these 208 genes were performed. Enriched genes were parts of 
various cellular organelles, besides those involved in various primary and cellular metabolic 
processes, cell communication, signal transduction, ion binding and transferase activity. Pathways 
regulating different amino acids metabolism were enriched in KEGG pathway analysis including 
steroid hormone and purine metabolism. Collectively, these observations describe the influence of 
E2 on CG DNA methylation in rainbow trout skeletal muscle. Further analysis of CHG and CHH 
methylations were in progress. Likewise, availability of completely annotated rainbow trout 
genome would enhance our capability in evaluation of gene expression guided by DNA 
methylation.   
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INTRODUCTION 
Rainbow trout skeletal muscle is an immediate energy source during gonadogenesis and 
increase in estrogen triggers these processes driving nutrient partitioning leading to increased 
protein degradation and decreased protein synthesis, depending on plane of nutrition. Various 
degradative pathways are highly expressed in rainbow trout as an influence of estrogen. During 
rainbow trout growth, hyperplasty and hypertrophy contribute to myogenesis that starts with 
proliferation of myogenic precursor cells (MPCs) present under the basal lamina. These MPCs 
further differentiate and mature to form a myofiber. Various signaling molecules and molecular 
factors regulate the differentiation of MPCs in development of mature muscle fibers. Epigenetics 
and non-coding RNA add an extra layer of regulation and play an important role in gene expression 
at transcriptional and post-transcriptional levels. Various studies emphasized specific DNA 
methylation in determining muscle cell lineage (COLLAS et al. 2008; SØRENSEN et al. 2009; 
SØRENSEN et al. 2010). Cells determined to commit to myogenic lineage demonstrate 
hypermethylation of genes responsible for adipogenic, osteogenic, pancreatic, neurogenic and 
epidermal lineage commitment (SØRENSEN et al. 2010). Concurrent hypomethylation of 
contractile muscle protein Obscurin, Myh7 and Myotilin was reported (CALVANESE et al. 2012). 
Demethylation was detected in many studies during the progression of myogenesis, thus activating 
muscle cell genes with specific changes that determine cell fate and terminal differentiation (CHIU 
AND BLAU ; TSUMAGARI et al. 2013; MIYATA et al. 2015). Most studies relative to DNA 
methylation and myogenesis focus primarily on global changes in DNA methylation and those that 
are specific to MyoD and myogenin genes. Expression of MyoD, an important myogenic 
regulatory factor, is necessary for myogenic cell fate decision is partially determined by DNA 
methylation at its distal regulatory region. This distal regulatory region, present 20kb upstream of 
TSS of MyoD is highly methylated in presomatic mesoderm cells but unmethylated in C2C12 
cells, as well as hindlimb and forelimb muscles (BRUNK et al. 1996). These experiments suggest 
that demethylation of the distal enhancer is necessary for MyoD gene expression. Similarly, 
demethylation of CpG, 340bp upstream of TSS of myogenin, is essential for the onset of myoblast 
differentiation. Methylation of this region allows binding of a repressor protein CIBZ that further 
blocks binding of the activator complex. Additional studies to understand gene regulation by DNA 
methylation of myogenin revealed non-CpG methylations in the myogenin promoter and these 
sites exhibit rapid demethylation when compared to CpG methylations.   Furthermore, regulation 
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of MyoD expression is also influenced by non-CpG methylations in its exon1 region. E2 exposure 
led to increased non-CpG methylation thus inversely regulating MyoD gene expression 
(RAMSAHOYE et al. 2000). Also, Pax7 and myostatin gene expression is negatively correlated with 
methylation in their promoter and exon1 regions respectively. A gradual increase in Pax7 
methylation was reported in differentiating C2C12 cells. Collectively these studies implicate the 
role of DNA methylation in timely regulation and precocious activation of gene expression in 
different stages of myogenesis. DNA methylation is not only confined to the myogenic genes but 
also regulates those involved in signaling pathways regulating myogenesis. Hypermethylation of 
IGF1 promoter is observed in slow-growing chickens with reduced gene expression. Most of the 
studies investigating regulation of gene expression revolved around CpG methylations. 
Availability of advanced sequencing techniques and bioinformatics tools allow exploration at base 
pair resolution, thereby revealing the occurrence of methylation at cytosines in CG, GHH and CHG 
contexts. CHH and CHG methylations are called non-CpG methylations, and differential 
methylation of such cytosines was observed as an effect of E2 in skeletal muscle of rainbow trout. 
Additionally, increased gene expression of maintenance and de novo methyltransferases DNMT1, 
DNMT3a and DNMT3b was observed in skeletal muscle exposed to E2 within 24hrs.  
Controlled regulation of DNA methylation is important to various contributing pathways 
and MRFs involved in myogenesis. We predict changes in the global methylation signature that 
further regulates gene expression in E2 exposed skeletal muscle. These skeletal muscle tissues 
were sequenced after bisulfite treatment, to describe global changes. DNA methylation is a 
dynamic process occurring at various stages of cell development, however no visible drastic 
changes in global methylation levels were observed in control and E2 treated samples. To further 
identify methylation changes differentially methylated regions were identified in CG/CHH/CHG 
contexts. Gene ontology and KEGG pathway analysis were performed for identified differentially 
methylated regions in CG context. A total of 201 genes were either hypo or hypermethylated with 
80% difference between control and E2 samples, 25 showed 100% difference in methylation rates. 
Though our previous studies report an extensive role of miRNAs and long non-coding RNAs in 
myogenesis of rainbow trout exposed to estrogen, not all differential gene expressions were 
explained by non-coding RNAs. Therefore, current study aimed at understanding the roles of DNA 
methylations that regulate changes in gene expressions influencing muscle synthesis in E2 exposed 
skeletal muscle.  
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METHODS 
Sample collection and DNA isolation  
Animal experiment was conducted at  the USDA/ARS National Center for Cool and Cold 
Water Aquaculture (KOGANTI et al. 2017a) including treatments with 17-estradiol, testosterone 
and DHT. Our current study was performed with samples treated with either vehicle or 17-
estradiol. The juvenile fish (each ~40 g) were treated with either vehicle or 17-estradiol, and their 
skeletal muscle collected after 24 hours. Treatments were carried out by intraperitoneal injections. 
Four skeletal muscle samples from each treatment were randomly selected and DNA isolated using 
Quick-DNATM Universal kit (Zymo Research) following manufacturer’s instructions. Briefly, 
skeletal muscle tissues were incubated overnight in solid tissue buffer provided in the kit and 
Proteinase K at 55oC for digestion followed by column purification. Purity was evaluated using a 
NanoDrop 1000 Spectrophotometer (Thermo Scientific). Equal concentrations of four control 
samples were pooled and its purity checked using Qubit (Life Technologies and Thermo Fisher 
Scientific); likewise, four estrogen samples were pooled and DNA purity checked before sending 
it for sequencing. These two samples, labelled control and E2 treatment, were sent for pair end 
(PE150) sequencing to Novogene (Beijing, China). Raw sequences obtained were filtered and 
differentially methylated regions were identified following pipeline presented in Fig. 1 
Methylation-specific restriction digestion assay and ELISA 
 Restriction digestion of 2 g of genomic DNA was performed at 37oC for 4 hours in a 50 
l reaction. Individual reactions with restriction enzymes Hha I, Hpa II, HpyCH4 IV and Dnp I 
were performed. Hha I, Hpa II and HpyCH4 IV identify cytosines that are not methylated but are 
followed by guanine, cytosine and adenine respectively. They cannot restrict DNA when the 
cytosines are methylated. Dnp I identified methylated adenine in DNA. The recognition sites were 
presented in Fig. 2. One percent agarose gel, with TAE buffer, was used to separate digested DNA 
and visualized using GelRed.  
 ELISA was performed to understand global methylation of cytosines using a 5-mC DNA 
methylation kit (Zymo Research) following manufacturer’s instructions. Briefly, 100 ng of DNA 
from 5 control and 5 E2 treated samples (24 hr samples) were denatured in a PCR machine at 98oC 
for 5 min using 5-mC coating buffer and immediately cooled on ice. Then, denatured DNA was 
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plated on an ELISA plate and incubated at 37oC for 1 hour. The plate was washed 3 times with 5-
mC ELISA buffer after discarding the DNA followed by incubation in the same buffer at 37oC for 
30 min. Subsequently, 5-mC ELISA buffer was discarded and primary antibody was added to the 
plate before incubating at 37oC for 1 hour. After incubation, the primary antibody was discarded, 
and the plate was washed three times using 5-mC ELISA buffer. Lastly, secondary antibody was 
added after washing primary antibody and the plate was incubated for 30 min before the absorption 
was measured at 405-450nm using an ELISA plate reader. A standard curve was made using the 
standards provided with the kit and is used to calculate percentage methylation in control and E2 
treated samples. Finally, cytosine methylation was calculated relative to control samples. A T-test 
was performed to determine significant differences in global methylation among the two 
treatments. 
Whole genome bisulfite sequencing 
 Library Construction and bisulfite treatment was performed at Novogene before 
sequencing. Briefly, genomic DNA was fragmented and purified before adaptor ligation and 
bisulfite conversion. The bisulfite converted DNA was further amplified by PCR and subjected to 
illumina sequencing. Paired-end sequencing was performed with a fragment size of 150bp each. 
Mapping and identification of methylated cytosines  
 BSseeker2 (GUO et al. 2013) is a Python-based programming tool to filter raw sequences 
obtained, map to the reference genome, and identify methylated cytosines. The sequences were 
first filtered for unique reads, this step helps to identify extremely amplified reads during PCR and 
eventually remove them. A reduced three letter approach (A, G, C/T) is used to map reads to the 
reference genome because unmethylated cytosines are converted to thymines during bisulfite 
treatment. Reference genome is indexed and converted using the three-letter approach. 
Simultaneously filtered unique reads are converted using the same approach and then mapped to 
the indexed reference genome. Once mapped, methylated cytosines were identified. mC in contexts 
of CpG, CpHpH and CpHpG along with their genomic coordinates were recognized. Lastly, 
identified methylated cytosines were processed using MethGo to characterize the coverage 
distribution and methylation profiling at the genome level. 
 114 
Identification of differentially methylated regions 
 Differentially methylated regions (DMRs) for control and E2 treated samples were 
identified using another python based package histogram of methylation, HOME 
(https://github.com/Akanksha2511/HOME#citation). Pairwise comparison of these regions was 
performed by HOME. The DMRs were identified depending on type of mC (CG, CHH or CHG). 
Downstream analysis after this step is performed with differential methylations of CG. DMRs with 
differences between control and E2 that are more than two times were filtered. Genomic 
coordinates of these DMRs were obtained to associate with available 46585 coding regions using 
RGmatch (FURIÓ-TARÍ et al. 2016). Gene ontology and KEGG pathways analysis was performed 
using Blast2Go for genes harboring DMRs. 
RESULTS 
Methylation-specific restriction digestion assay and ELISA 
 Hha I and Hpa II recognize cytosines in 5’ GCGC 3’ and internal cytosine in 5’ CCGG 3’ 
respectively, and they restrict DNA in regions that are not methylated. Similarly, Msp I recognize 
and restricts DNA with internal methylated cytosine in the sequence 5’ CCGG 3’. High molecular 
weight fragments were present after digestion with Hha I and Hpa II, these fragments were absent 
in Msp I digestion. This finding indicates the presence of CpG methylation in both control and 
estrogen treated samples. Distinct changes among the digestion patterns between control and E2 
treated samples were not observed (Fig. 2A, B and C). Likewise, digestion with HpyCH4 IV 
resulted in fewer high density DNA fragments when compared to Hha I and Hpa II. DNA was not 
significantly digested with Dnp I. 
 Relative, global methyl cytosine level was calculated between control and E2 samples 
using ELISA. The difference in DNA methylation between control and E2 treated samples is not 
significantly different at the global level (Fig. 3).   
Whole genome bisulfite sequencing 
Erwin Chargaff’s experiments to characterize DNA composition revealed that the number 
of guanines are equal to number of cytosines and the number of adenines to thymines (CHARGAFF 
1950; CHARGAFF 1951; CHARGAFF et al. 1952). Bisulfite treatment converts unmethylated 
cytosines to uracil that results in loss of complementarity between opposite strands of DNA. These 
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single strands can be further amplified using PCR, this amplification process replace uracils by 
thymines, consequently resulting in reduced GC content after bisulfite treatment (FROMMER et al. 
1992). Hence, distribution of these bases was checked for both reads that were sequenced. Cytosine 
content of read 1 and guanine content of the complementary read were very low because of the 
cytosine methylation as shown in Supplementary Fig. 1.  
A total of 669,056,192 reads were obtained from paired end sequencing of control and estrogen 
treated samples with an average of 30X coverage. Approximately 81% of reads in control and 87% 
in estrogen treated samples were retained after filtering the raw reads. Further processing of these 
reads by mapping to the reference genome and methylated cytosines in contexts of CG, CHH and 
CHG were identified. MethGo was used to understand changes in methylation at the global level; 
total coverage of methylation sites was represented by reverse cumulative plots (Fig. 4A and B). 
Control and estrogen treated samples exhibited 40% genome coverage with approximately around 
7X depth. These changes in methylation were also plotted in CG/CHH/CHG contexts. Graphs 
revealed an overlap of CG and CHG methylation, while CHH is comparatively lower across the 
genome. Additionally, fractions of total cytosine methylations are plotted relative to total 
percentage of CG/CHG/CHH methylations (Fig. 5A and B). The fractions of CG methylations in 
control and estrogen treated samples range from 0%-10% to 90%-100%; about 40% of total 
identified CG methylations showed 90-100% methylations. Whereas, more than 99% of total CHH 
and CHG methylations in control and estrogen treated muscle samples presented lower levels of 
methylation levels ranging from 0-10%. Further analysis was performed individually for different 
methylation patterns. Evaluation of CG methylations are presented as differential methylation in 
CHH and CHG contexts are still being processed.  
CpG methylations 
A total of about 43 million CG sites were identified in pooled DNA samples from 4 
individual rainbow trout skeletal muscle samples from control and estrogen treatments. 
Differentially methylated regions were identified using HOME program; the difference in percent 
methylation between control and estrogen samples was recorded as a change is methylation or 
delta. A total of 304 thousand regions were differentially methylated; of these regions, 140 
thousand were hypermethylated and 164 thousand were hypomethylated in the control. 
Methylation in these regions varied from 5% methylation to 100%, because the percentage of 
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methylation affects gene expression, regions with a delta value more than or equal to 80% were 
identified. There are 818 such regions that are either hyper or hypomethylated in E2 treated 
samples. Additionally, these regions were compared to the available rainbow trout transcriptomic 
data to identify differential methylation in regions common to those in coding genes. Of 818 
regions, 408 regions were matched to the genomic coordinates of transcriptomics data after 
removal of redundant regions; these regions were eventually mapped to different region in 208 
genes. Differential CG methylation of individual genes can also be visualized using Integrative 
Genome Viewer (IGV) (ROBINSON et al. 2011b) (Fig. 6). 
Genes with differentially methylated regions 
 Gene ontology and KEGG pathway analysis were performed using Blast2Go (CONESA et 
al. 2005) to identify the roles of 208 differentially methylated genes. GO terms that were obtained 
during gene ontology analysis were further scanned using InterProScan to obtain any of those 
missing in GO. The resultant identities from GO and InterProScan were merged for gene 
annotation. Genes involved in various biological processes, molecular functions, and cellular 
components were identified as differentially methylated between control and E2 treated samples 
(Fig. 7A, B and C). Genes involved in cellular and primary metabolic processes, cellular response 
to stimulus, cell communication, signal transduction, cellular component organization and 
anatomical structure development in biological processes differential methylation in E2 treated 
samples. Several differentially methylated regions associated with molecular functions include 
hydrolase, transferase, and binding to various proteins, carbohydrates, ions, cyclic and heterocyclic 
compounds. A large number of genes are also contributing to cellular components including 
membrane bound and non-membrane bound intracellular organelles, membrane components, parts 
of plasma membrane, and the endomembrane system. These genes were later mapped to reference 
KEGG pathways. Thirty-eight KEGG pathways were identified (Table 1). These KEGG pathways 
include steroid hormone biosynthesis and degradation, phosphatidylinositol signaling, inositol 
phosphate metabolism, and different amino acid metabolic pathways including lysine, 
phenylalanine, tyrosine, beta-alanine, glycine, serine, threonine, cysteine and methionine. Genes 
involved in cysteine and methionine metabolism were specifically regulating transfer of the 
adenosyl group to methionine, thus synthesizing s-adenosyl methionine (SAM), the primary 
methyl donor for DNA methylation (supplementary figure 2). Purine metabolism, nicotinate and 
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nicotinamide metabolism, ascorbate metabolism, and glycosphingolipid and sphingolipid 
metabolism are among the enriched KEGG pathways. Enriched KEGG pathways also include the 
phosphatidylinositol signaling system, Th1 and Th2 cell differentiation, the T cell receptor 
signaling pathway, and cell calcium signaling. 
Twenty-five of 208 differentially methylated genes were either 100% methylated in control 
or estrogen treated samples; 15 genes were hypermethylated and 10 were hypomethylated in 
control compared to E2 treated muscle. The list of the gene IDs, function and their chromosomal 
location were listed in Table 2. Hypermethylated genes in control include MTSS1 isoform X4, 
kinesin-1 heavy chain and hypomethylated genes are type 1 phosphatidylinositol 4,5-bisphosphate 
4-phosphatase and integrin beta-5.  
DISCUSSION 
 Global cytosine methylation was first identified using ELISA and methyl sensitive 
restriction digestion. Results from ELISA indicated no difference in DNA methylation percentage 
between E2 and control samples; it is necessary to consider the disadvantage of the technique with 
regard to DNA loading and its concentrations. Because DNA methylation is dynamic, it is 
advantageous to look at changes in DNA methylation at the gene level even when significant 
global methylation changes were not observed. Methyl sensitive digestion indicated cytosine 
methylations. Similarly, ELISA data do not show significant changes between control and E2 
treatment. 
 Methylation of cytosine is studied in contexts of CG, CHH and CHG while the epigenetic 
marks on CG is best characterized. These chemical modifications on cytosine contribute to 
regulation of the highly orchestrated process, gene expression. In this study, WGBS was performed 
to reveal changes in methylation as a direct or indirect effect of E2 on muscle development. WGBS 
gives an opportunity to detect cytosine methylation at a single-base-pair resolution. Bsseeker2 was 
used to align and map reads obtained from sequencing, which is believed to be more accurate and 
efficient. It uses a three-letter approach where all cytosines are converted to thymines in the 
reference genome and in filtered paired-end reads before mapping, compared to wild card 
approach followed in other available mapping software. A total of 43 million CG sites were 
identified, and methylation levels at each site were noted. Most of the CG sites were mapped to an 
unknown chromosome because the rainbow trout genome is not well annotated. Since the percent 
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methylation regulates gene expression, CG sites that show at least 80% hypo or hypermethylated 
were categorized. 
 Gene ontology of DMRs revealed changes in CG methylation patterns in genes including 
kinesin-1 heavy chain, MTSS isoform and integrin -5. Regions of 100% hyper or hypo 
methylation was observed in 25 genes and the remainder were more than 80%. Missing-in-
metastasis protein (MIM or MTSS1) is believed to be important in cytoskeletal remodeling, mostly 
acting downstream to tyrosine kinases and Rho-family GTPases (MATTILA et al. 2003; WOODINGS 
et al. 2003; BOMPARD et al. 2005; GONZALEZ-QUEVEDO et al. 2005; LIN et al. 2005). Mouse 
studies show that MTSS1 is capable of binding to the actin monomer, and inhibits actin filament 
nucleation by efficiently inhibiting nucleotide exchange (MATTILA et al. 2003). Overexpression of 
MTSS1 in bladder uroepithelium cell carcinoma reduced cell proliferation and cell cycle 
progression with no influence on cell apoptosis (DU et al. 2017). Also, MTSS1 mediates 
ubiquitination of chemokine receptor CXCR4 and facilitates degradation by E3 ubiquitin ligase 
(LI et al. 2017). This CXCR4 protein expression is repressed post-transcriptionally by the estrogen 
receptor, thus controlling cell migration in zebrafish (GAMBA et al. 2010). Together these studies 
indicate differential methylation of MTSS1due to E2 treatment, and control samples might regulate 
actin nucleation and cell migration. Current findings were also supported by our mRNA expression 
studies; downregulation was observed for genes involved in actin cytoskeleton, actin binding, and 
those involved in mesenchymal (precursors for MPCs) cell migration (WANG et al. 2017). 
Additional proteins with DMRs that are involved in actin polymerization and stabilization include 
dematin, serine threonine-kinase N1, LIM domain and actin-binding 1, and dystrophin. Knockout 
experiments in mouse embryonic fibroblasts found dematin is important in actin stress fiber 
formation, cell mobility and adhesion. LIM domain and actin-binding 1 binds to actin monomers 
and filaments, and it inhibits depolymerization of actin filaments. Dematin and actin binding 
proteins with a LIM domains bind to actin monomers and filaments, playing an important role in 
actin cytoskeleton regulation and maintenance of actin stability (MOHSENI AND CHISHTI 2008).  On 
the other hand, dystrophin is enriched in costamers that connects sarcomeres to cell membranes in 
striated muscle (ERVASTI AND CAMPBELL 1991; DMYTRENKO et al. 1993; RYBAKOVA et al. 2000). 
Muscular dystrophies were observed both in mouse and humans due to lack of dystrophin or its 
reduced expression (MINETTI et al. 1998; WILLIAMS AND BLOCH 1999; CLAFLIN AND BROOKS 
2008).  
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Serine threonine-kinase N1 (PKN1) is activated by small G proteins belonging to the Rho 
family (PALMER AND PARKER 1995), phosphoinositides (PALMER et al. 1995), and fatty acids 
(MUKAI et al. 1994). Over expression and expression of kinase defective PKN1 in fibroblasts and 
Rat1-IR cells indicate its role in cytoskeleton reorganization (DONG et al. 2000) through the insulin 
signaling pathway. PKN1 also interacts and phosphorylates a microfilament protein, -actinin, in 
a phosphatidylinositol 4,5 bisphosphate dependent manner (MUKAI et al. 1997); it affects 
contraction of myosin by phosphorylation of CPI-17, an inhibitor of myosin phosphatase 
(HAMAGUCHI et al. 2000). PKN1’s role in cell migration is suggested by studies confirming its 
function upstream to MAP kinase,s JNK and p38 (TAKAHASHI et al. 2003; KATO JR et al. 2008) 
and its association with changes in focal adhesions (LACHMANN et al. 2011). Supportive evidence 
for a functional role of PKN1 in regulation of muscle contraction/relaxation and force transmission 
is presented by studies in roundworm (QADOTA et al. 2011). Moreover, PKN1 regulates activity 
of various transcription factors necessary for myogenic terminal differentiation; differentiation of 
C2C12 cells was inhibited in the presence of mutated PKN1 (CHEN et al. 2015). Furthermore, 
PKN1 regulate a nuclear import of class IIa histone deacetylases (HDAC) by phosphorylation of 
nuclear localization signal in HDAC5, 7 and 9, thereby partially regulating gene expression by 
impairing the import of transcriptional repressors (HARRISON et al. 2010). Similar observations in 
prostate cancer cells reveal that phosphorylation of histone 3 at threonine 11 regulates transcription 
of genes that are also regulated by the androgen receptor. Androgen receptor induced cell 
proliferation is inhibited by PKN1 repression (METZGER et al. 2008).  
Arf-GAP, with Rho-GAP ANK repeat and PH domain-containing 1-like (ARAP1), is 
specific to vertebrates, it exerts control in intracellular signaling and cytoskeleton structure. 
Overexpression of ARAP resulted in increased expression of a cell division protein 42 homolog 
which helps in extension and maintenance of filopodia, actin rich surface projections, and the 
homolog also mediates cell migration (GAUTHIER-CAMPBELL et al. 2004; MODZELEWSKA et al. 
2006). ARAP1 serves as a node in a signaling network that facilitates actin remodeling and thus 
cell movement (MIURA et al. 2002). In total, these studies indicate the role of differentially 
methylated genes in actin, cytoskeleton maintenance and also in cell migration, terminal 
differentiation of myoblasts, and regulation of histone modifications. Cellular components, 
enriched using Blast2GO, revealed DMR in genes that regulate membrane bound and non-
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membrane bound intracellular organelles, plasma membrane and those that are involved in 
maintaining cell periphery. 
Kinesin-1 heavy chain (KIF5B) is expressed ubiquitously with abundant expression in 
heart, skeletal muscle, and intestine (HOLLENBECK 1989). KIF5B significantly regulates myofibril 
assembly and muscle tendon junction stability. Not surprisingly, KIF5B knock out mice exhibited 
aggregates of myosin and actin, detachment of myofibrils from the sarcolemma, and mis-localized 
desmin and nestin (WANG et al. 2013). Moreover, KIF5B is necessary for positioning nuclei during 
myoblast differentiation and for distribution of mitochondria and lysosomes (WANG AND 
SCHWARZ 2009; METZGER et al. 2012). In addition to genes regulating different structural aspects 
of myogenesis, genes involved in signaling pathways were also differentially methylated. 
Differentially methylated genes, with delta value  80, are listed in Supplementary Table 1. 
 Nuclear receptor-interacting 2-like (NRIP2) is well studied in cancer cells because of 
increased expression in colorectal cancers. Overexpression of NRIP2 resulted in self-renewal of 
colorectal cancer initiating cells and increased Wnt activity (PAN et al. 2017; WEN et al. 2017). 
Differential methylation of NRIP2 is also observed in breast cancer (ZHANG et al. 2015). 
Moreover, estrogen regulates expression of NRIP2, and a significant decrease in NRIP2 was 
observed in ovariectomized mice (PIAO et al. 2017). The same study reported a critical role for 
NRIP2 in estrogen mediated bone resorption, osteoclasts differentiation, and apoptosis. This 
interacting protein is capable of functioning as a transcriptional coactivator or corepressor besides 
being a transcriptional regulator of estrogen signaling (KISKINIS et al. 2007; PIAO et al. 2017). Its 
role is well documented in adipogenesis and bone metabolism, further investigation is needed to 
understand its regulation in myogenesis.  
Genes that are core components of ubiquitin ligases and different ubiquitin ligases were 
differentially methylated in the current study. These genes include E3 ubiquitin-ligase CHIP, 
cullin-9-like isoform X4, E3 ubiquitin-ligase MYCBP2-like, pre-mRNA-processing factor 19, and 
E3 ubiquitin-ligase RAD18-like isoform X1. E3 ubiquitin-ligase CHIP acts as cochaperone 
interacting with various proteins to deliver misfolded and partially folded proteins to proteasomes 
(DEMAND et al. 2001; MEACHAM et al. 2001). This ubiquitin ligase is highly expressed in tissues 
with high metabolic activity and protein turnover, such as skeletal muscle (BALLINGER et al. 1999). 
Cullin-9 is an essential element of the Cul9-RING ubiquitin protein ligase complex that mediates 
ubiquitination and degradation. Cul9 is involved in maintenance of microtubule integrity and 
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dynamics; it also binds to survivin for further ubiquitination and degradation (LI et al. 2014). 
Survivin is a multifunctioning protein necessary during cell division. E3 ubiquitin-ligase 
MYCBP2-like interacts with E2 enzymes, mediating ubiquitination and eventually proteasomal 
degradation. Besides, it may play a role in synaptogenesis and facilitating transcriptional activation 
by MYC (HAN et al. 2008).  Two other aforementioned factors, pre-mRNA-processing factor 19, 
and E3 ubiquitin-ligase RAD18-like isoform X1, are also involved in repairing DNA damage, 
mRNA splicing, and other repair mechanisms including ubiquitination and degradation 
(HATAKEYAMA et al. 2001; UNK et al. 2006; SONG et al. 2010; COTTA-RAMUSINO et al. 2011). 
Increased expression of genes involved in ubiquitin conjugating enzyme complex was observed in 
our previous study (WANG et al. 2017). Our current findings and these observations together 
implicate DNA methylation as a major regulator of ubiquitin conjugating enzyme complex gene 
expression. Additionally, anti-apoptotic NR13-like and deleted in malignant brain tumors 1–like 
genes with roles in apoptosis are differentially methylated. 
Furthermore, differentially methylated regions were identified in genes involved in regular 
cell mechanisms; these genes include TATA box-binding-associated factor RNA polymerase I 
subunit B, elongation factor 1-delta isoform X1, and eukaryotic translation initiation factor 3 
subunit B. TATA box-binding-associated factor RNA polymerase I subunit B is involved in 
various steps of transcription, including assembly of pre-initiation complex and postpolymerase 
recruitment events during rRNA transcription (NAIDU et al. 2011). Eukaryotic translation initiation 
factor 3 subunit B and elongation factor 1-delta isoform X1 play essential roles in translation 
(MASUTANI et al. 2007). Small RNAs regulate gene expression by translational repression in 
animals and this process is further regulated by DNA methylation. Differential methylation of 
trinucleotide repeat-containing gene 6B-like (TNRC6B) was observed (Supplementary Table 1.) 
with a delta value  (80) between control and E2 treated samples. TNRC6B is necessary for 
miRNA dependent translational repression and eventual deadenylation (MEISTER et al. 2005; 
ZIPPRICH et al. 2009; BRAUN et al. 2011). Genes that regulate gene expression through DNA and 
histone methylation were also differentially methylated. Activating transcription factors, 7-
interacting 1-like and histone-lysine N-H3 lysine-36 and H4 lysine-20 specific-like, regulates 
transcription through their epigenetic mechanisms. These two genes can act as transcriptional 
repressors and activators either aiding in gene expression or chromatin formation (QIAO et al. 
2011; TIMMS et al. 2016). S-adenosylmethionine synthase-like isoform X2 is necessary for the 
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formation of S-adenosylmethionine (SAM) from methionine and ATP, with release and 
subsequent hydrolysis of triphosphate. Differential methylation of this gene would either increase 
or decrease SAM availability, which is a methyl donor for DNA methylation. Even though, 
significant changes were not observed in DNA methylation at the genome level, differential 
methylation of S-adenosylmethionine could explain changes in DNA methylation at the gene level. 
Chromodomain-helicase-DNA-binding 7-like (CHD7) is another gene that is differentially 
methylated and involved in cell fate decisions. CHD7 modulates epigenetic and signaling 
pathways and regulates gene expression by binding to active enhancer elements and recruiting 
transcription factors in stem cells increasing their pluripotency (ZENTNER et al. 2011; MICUCCI et 
al. 2015). 
Previous studies focused on describing differential expression of miRNA, mRNA and 
lncRNAs (KOGANTI et al. 2017a; WANG et al. 2017a), and they indicate changes in calcium ion 
and associated signaling pathways. Increased mitochondrial outer membrane permeability was 
believed to be a consequence of increased reactive oxygen species and calcium signaling. 
Similarly, lncRNAs-pathway network suggested 15 differentially expressed lncRNAs among 
control and E2 treated samples; these lncRNAs were linked to calcium signaling pathways. 
Supporting our previous studies, more than 10 genes that are differentially methylated were 
directly or indirectly involved in cellular calcium homeostasis and calcium signaling 
(Supplementary Table 1). These genes collectively are regulators of Ca2+ influx (LIOU et al. 2005; 
ROOS et al. 2005) and release of and Ca2+ dependent exocytosis; they are calcium-binding 
transmembrane components. Many of these genes are involved in release of calcium into the 
cytoplasm of muscle cells thus regulating their contraction (SCHWARZMANN et al. 2002).   
Collectively, these observations indicate a significant role for DNA methylation in 
maintenance of muscle cell structure, protein turnover, calcium signaling and ubiquitination. All 
these, directly or indirectly, contribute to the physiological changes observed in E2 treated rainbow 
trout skeletal muscle. Further functional analysis of DNA methylation at the individual gene level 
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Figure 1. Pipeline used to identify differentially methylated regions. 
The flow chart indicates the sequence of steps followed to identify DMRs, the software tools and 
packages used for those steps are shown in the boxes.  
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Figure 2. Methyl-specific restriction enzyme analysis of genomic DNA. 
Restriction digestion of control and E2 treated samples (n = 3) with (A) Hha I and Hpa II (B) 
HpyCH4 IV and Msp I ( C) Dnp I. C1, C2 and C3 represent control samples; E1, E2 and E3 
represent estrogen treated samples. Below the restriction digestion gel picture the recognition site 





Figure 3. ELISA to identify global methyl cytosine levels. 
Results are expressed as fold change ± SE (n = 5). Student’s T-test was performed and no 











































Percentage of respective sites (y-axis) and their coverage (x-axis) during sequencing are plotted in 
a reverse cumulative plot. The green represents CG methylation which is overlapped by CHG (blue 









Figure 5. Global methylated cytosine distribution. 
Distribution of global cytosine methylation in control (A) and E2 treated sample (B). The fraction 
of total CG, CHG and CHH methylation (y-axis) and the percentage of each fraction (x-axis) 












Signal peptide peptidaselike 2B 
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Figure 6. Differentially methylated regions visualized using IGV. 
Gene E3 ubiquitin-ligase CHIP is on the negative strand while Signal peptide peptidase like 2B is 
on the positive strand. The axis was set to 50% methylation which allows us to visualize 
























Figure 7. Gene Ontology analysis of gene with differentially methylated regions (CG). 





Table 1. KEGG pathways analysis of genes with differentially CG methylated regions. 
Pathway Pathway ID 
Mannose type O-glycan biosynthesis map00515 
Lysine degradation map00310 
Glycosaminoglycan biosynthesis - heparan sulfate / heparin map00534 
Nicotinate and nicotinamide metabolism map00760 
Steroid hormone biosynthesis map00140 
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate map00532 
Purine metabolism map00230 
Steroid degradation map00984 
Glycerolipid metabolism map00561 
Glycosphingolipid biosynthesis - ganglio series map00604 
Drug metabolism - cytochrome P450 map00982 
Retinol metabolism map00830 
Ether lipid metabolism map00565 
Metabolism of xenobiotics by cytochrome P450 map00980 
Phenylalanine metabolism map00360 
Sphingolipid metabolism map00600 
Nitrogen metabolism map00910 
Tyrosine metabolism map00350 
Pentose and glucuronate interconversions map00040 
Aminobenzoate degradation map00627 
Tropane, piperidine and pyridine alkaloid biosynthesis map00960 
Mucin type O-glycan biosynthesis map00512 
Glycerophospholipid metabolism map00564 
Phosphatidylinositol signaling system map04070 
Glycosaminoglycan biosynthesis - keratan sulfate map00533 
Thiamine metabolism map00730 
Cysteine and methionine metabolism map00270 
Inositol phosphate metabolism map00562 
beta-Alanine metabolism map00410 
Glycine, serine and threonine metabolism map00260 
Drug metabolism - other enzymes map00983 
Ascorbate and aldarate metabolism map00053 
Th1 and Th2 cell differentiation map04658 
T cell receptor signaling pathway map04660 
Glycosphingolipid biosynthesis - globo and isoglobo series map00603 
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Porphyrin and chlorophyll metabolism map00860 
Glycosphingolipid biosynthesis - lacto and neolacto series map00601 
Isoquinoline alkaloid biosynthesis map00950 
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Table 2. DMRS with delta = 100. 
List of Gene IDs, their description and chromosomal location of genes with differentially methylated regions (delta value = 100). 
Gene ID Gene Description Chromosomal location 
GSONMT00043412001 MTSS1 isoform X4 chrUn_177795616_177795843 
GSONMT00047294001 NLR family CARD domain-containing 3-like chrUn_52742408_52742790 
GSONMT00052262001 T-lymphoma invasion and metastasis-inducing 2 chrUn_100101932_100102003 
GSONMT00049850001 SH3 and multiple ankyrin repeat domains 3-like chrUn_466526627_466526752 
GSONMT00037508001 type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase 
chrUn_8_2184766_2184820 
2184793 
GSONMT00063837001 cell wall DAN4- chrUn_516413858_516413932 
GSONMT00009689001 oocyte zinc finger 6-like chrUn_891648_891791 
GSONMT00049306001 dymeclin isoform X2 chrUn_334685344_334685472 
GSONMT00046774001 integrin beta-5 chrUn_1065978247_1065978298 
GSONMT00063536001 RNA binding fox-1 homolog 2-like isoform X2 chrUn_1065978247_1065978298 
GSONMT00045523001 zinc-binding alcohol dehydrogenase domain-containing 2 chrUn_183919601_183919676 
GSONMT00015086001 desmoglein-2-like chrUn_5_25492875_25493239 
GSONMT00017342001 beta-galactosidase-1 2 chrUn_24_4446695_4446767 
GSONMT00017343001 galactosylgalactosylxylosyl 3-beta-glucuronosyltransferase 1 chrUn_24_4446695_4446767 
GSONMT00031753001 serine threonine- kinase D3-like chrUn_29_2363855_2364050 
GSONMT00031754001 unnamed protein product chrUn_29_2363855_2364050 
GSONMT00008846001 forkhead box P3 chrUn_16_35686473_35686576 
GSONMT00013218001 unnamed protein product chrUn_20_17993397_17993466 
GSONMT00036928001 nuclear receptor coactivator 6-like isoform X1 chrUn_142652331_142652448 
GSONMT00030380001 kinesin-1 heavy chain chrUn_11_45310313_45310530 
GSONMT00036502001 Golgi SNAP receptor complex member 2 chrUn_12_1756822_1756929 
GSONMT00013489001 





arf-GAP with Rho-GAP ANK repeat and PH domain-
containing 1-like 
chrUn_12_22210482_22210695 
GSONMT00072683001 hepatic leukemia factor-like chrUn_1055141136_1055141201 







Supplementary figure 1. Distribution of GC content. Position of a base on the read is on x-axis and 
the percentage of each base on y-axis. A-T content of each read is more than the G-C content due 





Supplementary figure 2. Gene with differentially methylated regions in enzyme (yellow box) 
necessary for conversion of methionine to s-adenosyl methionine (SAM), a methyl donor for DNA 
methylation. 
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Supplementary table 1. List of Gene IDs and their description with differentially methylated 
regions (delta value  80)  
Gene ID Gene Description 
GSONMT00038395001 neurobeachin-like isoform X2 
GSONMT00040894001 serine threonine- kinase N1-like isoform X2 
GSONMT00018560001 otopetrin-3-like isoform X2 
GSONMT00033489001 voltage-dependent L-type calcium channel subunit alpha-1S 
GSONMT00047032001 ATP synthase subunit mitochondrial-like 
GSONMT00000329001 GMP synthase [glutamine-hydrolyzing] 
GSONMT00032945001 matrix metallo ase-9-like 
GSONMT00024979001 eukaryotic translation initiation factor 3 subunit B 
GSONMT00008583001 RNA-directed DNA polymerase from mobile element jockey 
GSONMT00062010001 unnamed protein product, partial 
GSONMT00009581001 splicing arginine serine-rich 15-like 
GSONMT00024985001 circularly permutated Ras 1-like 
GSONMT00016042001 amine oxidase [flavin-containing]-like 
GSONMT00003645001 zinc finger MIZ domain-containing 2-like isoform X3 
GSONMT00043422001 unnamed protein product 
GSONMT00060724001 poly [ADP-ribose] polymerase 11-like 
GSONMT00046724001 stromal interaction molecule 1-like isoform X1 
GSONMT00028745001 calcium-activated potassium channel subunit alpha-1- 
GSONMT00045996001 DNA replication licensing factor MCM4 
GSONMT00015659001 sodium-dependent neutral amino acid transporter B(0)AT1-like 
GSONMT00003976001 nuclear receptor-interacting 2-like 
GSONMT00062759001 T-cell receptor beta 
GSONMT00062760001 T-cell receptor beta 
GSONMT00023748001 sciellin isoform X1 
GSONMT00052213001 anti-apoptotic NR13-like 
GSONMT00042290001 ataxin-1-like 
GSONMT00005606001 potassium voltage-gated channel subfamily H member 4 
GSONMT00028833001 CYR61-like 
GSONMT00031243001 cysteine serine-rich nuclear 3-like isoform X1 
GSONMT00005364001 TC1-like transposase 
GSONMT00043412001 MTSS1 isoform X4 
GSONMT00020618001 unnamed protein product 
GSONMT00016279001 spidroin-1-like isoform X1 
GSONMT00002804001 cell migration-inducing and hyaluronan-binding 
GSONMT00002504001 dmX 2 
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GSONMT00001099001 and PH domain-containing 5-like isoform X2 
GSONMT00061970001 cytochrome P450 26A1 
GSONMT00047294001 NLR family CARD domain-containing 3-like 
GSONMT00056448001 unconventional myosin-IXa-like 
GSONMT00002151001 LIM domain and actin-binding 1-like isoform X1 
GSONMT00042327001 RNA-directed DNA polymerase from mobile element jockey- 
GSONMT00030193001 low-density lipo receptor-related 4 isoform X1 
GSONMT00025849001 phospholipid phosphatase-related type 5-like isoform X1 
GSONMT00003392001 zinc finger 
GSONMT00052262001 T-lymphoma invasion and metastasis-inducing 2 
GSONMT00010108001 RNA-directed DNA polymerase from mobile element jockey- 
GSONMT00010098001 membrane-associated phosphatidylinositol transfer 3 
GSONMT00061299001 dystrophin-related 2-like 
GSONMT00049335001 inosine-uridine preferring nucleoside hydrolase-like 
GSONMT00044284001 Bardet-Biedl syndrome 4 -like isoform X2 
GSONMT00049850001 SH3 and multiple ankyrin repeat domains 3-like 
GSONMT00037508001 type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase 
GSONMT00009207001 U6 snRNA-associated Sm LSm3 
GSONMT00063837001 cell wall DAN4- 
GSONMT00009689001 oocyte zinc finger 6-like 
GSONMT00062700001 LIM domain and actin-binding 1-like isoform X1 
GSONMT00004147001 E3 ubiquitin- ligase CHIP 
GSONMT00027340001 inter-alpha-trypsin inhibitor heavy chain H5 
GSONMT00000030001 interleukin-21 receptor isoform X1 
GSONMT00049306001 dymeclin isoform X2 
GSONMT00005828001 cysteine-rich motor neuron 1 
GSONMT00046774001 integrin beta-5 
GSONMT00063536001 RNA binding fox-1 homolog 2-like isoform X2 
GSONMT00062936001 piggyBac transposable element-derived 3-like 
GSONMT00062937001 hepatocyte cell adhesion molecule- 
GSONMT00025140001 zinc finger MIZ domain-containing 1-like isoform X5 
GSONMT00018442001 peroxisomal carnitine O-octanoyltransferase-like 
GSONMT00029013001 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-
sialyltransferase 1-like 
GSONMT00055168001 rho GTPase-activating 21-like isoform X1 
GSONMT00035139001 transmembrane 94-like isoform X1 
GSONMT00055431001 tetratricopeptide repeat 22 
GSONMT00013110001 cAMP-dependent kinase type II-alpha regulatory subunit-like 
isoform X2 
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GSONMT00041814001 collagen alpha-1(V) chain-like isoform X2 
GSONMT00014867001 repressor of yield of DENV 
GSONMT00044531001 desmoplakin isoform X2 
GSONMT00010477001 ATP-binding cassette sub-family E member 1 
GSONMT00045523001 zinc-binding alcohol dehydrogenase domain-containing 2 
GSONMT00001103001 Golgi SNAP receptor complex member 1 
GSONMT00003333001 bicaudal D homolog 1-like 
GSONMT00044390001 kelch 29 
GSONMT00006838001 U6 snRNA-associated Sm LSm7 
GSONMT00006841001 signal peptide peptidase-like 2B 
GSONMT00041952001 interferon-induced very large GTPase 1-like 
GSONMT00022513001 thyroid hormone receptor-associated 3 isoform X4 
GSONMT00010472001 immmunoglobulin light chain 
GSONMT00015086001 desmoglein-2-like 
GSONMT00022139001 cullin-9-like isoform X4 
GSONMT00022140001 cullin-9-like isoform X3 
GSONMT00032029001 PDZ and LIM domain 5-like 
GSONMT00006955001 zinc finger 813-like 
GSONMT00062416001 deoxyribodipyrimidine photo-lyase-like 
GSONMT00034452001 phospholipid phosphatase 2-like 
GSONMT00029414001 dnaJ homolog subfamily C member 3-like 
GSONMT00017342001 beta-galactosidase-1 2 
GSONMT00017343001 galactosylgalactosylxylosyl 3-beta-glucuronosyltransferase 1 
GSONMT00019877001 gastrula zinc finger -like 
GSONMT00010391001 striatin-4 isoform X2 
GSONMT00010392001 serine threonine- kinase D2 
GSONMT00010318001 lutropin-choriogonadotropic hormone receptor-like 
GSONMT00050171001 116 kDa U5 small nuclear ribonucleo component 
GSONMT00050175001 60S ribosomal L19 
GSONMT00040445001 vacuolar sorting-associated 13A isoform X1 
GSONMT00015115001 insulin receptor substrate 2-like isoform X1 
GSONMT00007270001 carbonic anhydrase 4-like 
GSONMT00037482001 TCR-gamma constant region 
GSONMT00031753001 serine threonine- kinase D3-like 
GSONMT00031754001 unnamed protein product 
GSONMT00009908001 spondin-1-like isoform X1 
GSONMT00061869001 activating transcription factor 7-interacting 1-like 
GSONMT00061870001 activating transcription factor 7-interacting 1-like 
GSONMT00008846001 forkhead box P3 
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GSONMT00013218001 unnamed protein product 
GSONMT00056810001 trinucleotide repeat-containing gene 6B -like 
GSONMT00056812001 casein kinase I 
GSONMT00038125001 coiled-coil domain-containing 174 
GSONMT00014754001 E3 ubiquitin- ligase MYCBP2-like 
GSONMT00052207001 NHS 1 isoform X3 
GSONMT00036928001 nuclear receptor coactivator 6-like isoform X1 
GSONMT00036934001 solute carrier family 26 member 6-like 
GSONMT00040610001 MTSS1 isoform X3 
GSONMT00010157001 SRSF kinase 3-like isoform X3 
GSONMT00051319001 calcium-dependent secretion activator 1- 
GSONMT00044026001 grainyhead 1 homolog isoform X2 
GSONMT00044027001 TATA box-binding -associated factor RNA polymerase I subunit B 
GSONMT00050547001 long-chain-fatty-acid-- ligase 1-like isoform X1 
GSONMT00042791001 beta-galactoside alpha-2,6-sialyltransferase 2 
GSONMT00042793001 RNA-directed DNA polymerase from mobile element jockey 
GSONMT00043680001 B-cell receptor CD22-like 
GSONMT00059137001 zinc finger 19-like 
GSONMT00049831001 LIM domain transcription factor -like isoform X1 
GSONMT00025587001 manganese-transporting ATPase 13A1 
GSONMT00034033001 Krueppel-like factor 6 
GSONMT00029702001 F-actin-methionine sulfoxide oxidase mical1-like isoform X1 
GSONMT00030380001 kinesin-1 heavy chain 
GSONMT00001799001 HRAS-like suppressor 2 
GSONMT00001800001 deleted in malignant brain tumors 1 -like 
GSONMT00036502001 Golgi SNAP receptor complex member 2 
GSONMT00016924001 hepatocyte cell adhesion molecule-like isoform X2 
GSONMT00016934001 transmembrane and coiled-coil domain-containing 6 
GSONMT00044813001 secretin receptor-like isoform X1 
GSONMT00044814001 cilia- and flagella-associated 221 isoform X1 
GSONMT00055123001 ryanodine receptor 3-like isoform X2 
GSONMT00044303001 CLIP-associating 1-B-like 
GSONMT00044314001 disrupted in renal carcinoma 2 
GSONMT00009799001 paired box Pax-6-like 
GSONMT00021806001 dematin-like isoform X1 
GSONMT00040393001 pre-mRNA-processing factor 19 
GSONMT00019027001 contactin-4-like isoform X1 
GSONMT00013489001 arf-GAP with Rho-GAP ANK repeat and PH domain-containing 1-
like 
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GSONMT00013490001 arf-GAP with Rho-GAP ANK repeat and PH domain-containing 1-
like 
GSONMT00024682001 calcium-binding tyrosine phosphorylation-regulated isoform X1 
GSONMT00027156001 rho GTPase-activating 32-like isoform X1 
GSONMT00012762001 paired box and transposase domain containing 
GSONMT00037200001 polypyrimidine tract-binding 2-like 
GSONMT00034929001 unnamed protein product 
GSONMT00058462001 T-cell receptor alpha chain V region HPB-MLT precursor 
GSONMT00039234001 latent-transforming growth factor beta-binding 2 isoform X1 
GSONMT00010006001 dynein heavy chain axonemal 
GSONMT00076862001 ATP-binding cassette sub-family A member 12 
GSONMT00076439001 teneurin-2 isoform X1 
GSONMT00075587001 rhotekin-2 isoform X2 
GSONMT00075537001 chromodomain-helicase-DNA-binding 7-like 
GSONMT00074889001 tetratricopeptide repeat 28-like 
GSONMT00074843001 phospholipase D3 
GSONMT00074457001 voltage-dependent L-type calcium channel subunit alpha-1S 
GSONMT00074458001 voltage-dependent L-type calcium channel subunit alpha-1S 
GSONMT00074178001 casein kinase I isoform X1 
GSONMT00073410001 Fanconi anemia group M 
GSONMT00073089001 serine threonine- kinase TNNI3K 
GSONMT00072683001 hepatic leukemia factor-like 
GSONMT00072116001 nucleo TPR-like isoform X1 
GSONMT00072085001 exostosin-1c isoform X1 
GSONMT00072044001 myosin-binding cardiac-type-like 
GSONMT00071418001 histone-lysine N- H3 lysine-36 and H4 lysine-20 specific-like 
GSONMT00071319001 transmembrane 168-A-like 
GSONMT00070672001 E3 ubiquitin- ligase RAD18-like isoform X1 
GSONMT00070160001 S-adenosylmethionine synthase-like isoform X2 
GSONMT00069974001 rootletin isoform X1 
GSONMT00068112001 potassium voltage-gated channel subfamily S member 3 
GSONMT00067850001 V-type proton ATPase 116 kDa subunit a-like 
GSONMT00067851001 V-type proton ATPase 116 kDa subunit a-like 
GSONMT00067164001 serine threonine- phosphatase 2B catalytic subunit alpha isoform 
isoform X1 
GSONMT00067165001 serine threonine- phosphatase 2B catalytic subunit alpha isoform 
isoform X2 
GSONMT00067170001 NXPE family member 3-like 
GSONMT00066366001 F-box LRR-repeat 17 
GSONMT00065409001 dysbindin-like isoform X1 
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GSONMT00065314001 elongation factor 1-delta isoform X1 
GSONMT00065336001 desmoplakin-like isoform X1 
GSONMT00065337001 desmoplakin-like isoform X1 
GSONMT00082648001 fibroblast growth factor receptor 2 isoform X1 
GSONMT00082323001 B-cell receptor-associated 29-like 
GSONMT00082036001 3-oxo-5-alpha-steroid 4-dehydrogenase 2-like 
GSONMT00081780001 pleckstrin homology domain-containing family A member 6-like 
isoform X6 
GSONMT00080026001 SNF-related serine threonine- kinase-like 
GSONMT00079425001 serine threonine- kinase D3-like isoform X1 
GSONMT00079375001 serine threonine- phosphatase 2A 55 kDa regulatory subunit B alpha 
isoform 
GSONMT00079136001 transcriptional activator GLI3 isoform X2 
GSONMT00078403001 rab11 family-interacting 3 isoform X2 
GSONMT00076795001 collectin-11 isoform X2 
GSONMT00074009001 zinc finger 629-like 
GSONMT00072782001 phosphatase 1 regulatory subunit 12A 
GSONMT00072163001 FAM184A-like isoform X1 
GSONMT00072208001 band 2 isoform X1 
GSONMT00069684001 polypeptide N-acetylgalactosaminyltransferase 5 
GSONMT00067744001 peptidyl-prolyl cis-trans isomerase FKBP7 
GSONMT00077787001 MAGUK p55 subfamily member 7-like 
GSONMT00070911001 plexin domain-containing 2 
GSONMT00064098001 diacylglycerol kinase zeta-like isoform X1 
GSONMT00066506001 tyrosine- kinase Yes 
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miR-nov-285-3p regulates DNA methyltransferase1 expression 
INTRODUCTION 
miRNAs regulate gene expression post transcriptionally either by deadenylation or 
translational repression. They functionally reduce gene expression by binding to the 3’ region of 
mRNA generally besides regulating gene expression by binding to 5’ UTR and coding regions.  
Target gene prediction of this novel miRNA and subsequent gene ontology enrichment analysis 
revealed roles in biological processes and molecular functions involving DNA, RNA and histone 
methylation and mRNA capping as shown is table 1. In general, these processes directly or 
indirectly regulate gene expression. This novel miRNA showed reduced expression in E2 exposed 
skeletal muscle in comparison to control (Chapter 1, Figure 2). Supplementary to this study, 
expression analysis of DNA methyltransferases also confirmed an increase in all three DNMTs in 
skeletal muscle under the influence of estrogen after 24 hours (Chapter 2, Figure 2). Collectively, 
these findings directed our interest to investigate and functionally validate the role of this novel 
miRNA in Dnmt1 gene expression. 
Cloning and plasmid purification 
Dnmt1 gene and pre-miR-nov-285 sequences were obtained and their intramolecular 
hybridization was confirmed using RNA hybrid software (Figure 1). The seed sequence of this 
novel miRNA binds to the last exon of Dnmt1. Primers were designed with Pme1 and Xho1 
restriction enzymes at the 5’ and 3’ ends respectively, to amplify a 252bp fragment from E2 
exposed skeletal muscle cDNA samples. This 252bp fragment is from the last exon of Dnmt1 that 
harbors sequence complementary to the seed sequence. The amplified fragment was successively 
cloned to pmirGLO dual-luciferase miRNA target expression vector (Promega, Madison, WI, 
USA) downstream of firefly luciferase (Figure 2a). Concurrently, a 253 bp fragment of pre-miR-
285-3p was amplified from testis cDNA and cloned to pcDNA3.1a using BamH1 and Xho1 
(Figure 2b). Primers used for cloning were listed in table 2. Further, these clones were confirmed 
using Sanger’s sequencing. Both the clones, pmiRGLO and pcDNA3.1a plasmids were later 
purified using Qiagen plasmid purification midi kit following manufacturer’s instructions.  
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Cell culture and dual luciferase reporter assay 
 Human embryonic kidney cells line (HEK-293) was used for the luciferase reporter assay. 
The cells were maintained in 10mm plate at 37oC in 5% CO2 using 10% fetal bovine serum (Gibco-
BRL, Grand Island, NY, USA) supplemented DMEM/High glucose medium. These cells were 
plated in a 96-well plate with a density of 2 X 104 cells/well. Transfection was performed using 
Lipofectamine LTX transfection reagent following manufacturer’s instructions (Invitrogen™, 
Thermo Fisher Scientific, Waltham, MA, USA). PmiRGLO-3’DNMT is cotransfected with 
increasing concentrations of pcDNA3.1a-pre-miR285. The total amount of plasmid used for 
transfection was 100ng/well. Transfection was repeated 4 times in 3 independent experiments. 
Fortyeight hours post-transfection cells were collected and luciferase activity measured using 
Dual-Glo System (Promega, Madison, WI, USA). Firefly and renilla luciferase activity was 
measured following Dual-Glo Luciferase Assay protocol and statistical significance of differential 
luciferase activity was determined by Students t-test.  
Luciferase activity 
 Firefly luciferase activity was normalized by dividing with renilla luciferase activity. 
Luciferase activity was represented as relative expression to pmiRGLO-3’Dnmt which is set as 1. 
pmiRGlo vector cotransfected with pcDNA3.1 was used as a control, to compare the luciferase 
activity of pmiRGLO-3’Dnmt with pcDNA3.1-pre-miR-285 at different concentrations. (Figure 
3). Significant reductions in gene expression were observed with increasing pre-miR285 
concentrations. These observations support the idea that miR-nov-285-3p regulates Dnmt1 gene 







Figure 1. Binding of seed sequence to last exon of Dnmt1. 








Figure 2. Cloning strategies.  
Cloning of the 3’ exon region of Dnmt1 with complementary sequence for mature miRNA in 
pmiRGLO vector (A), cloning of pre-miR285-3p with seed sequence in pcDNA3.1a (B). The 
primers used to amplify are in black and underlined, the target region and mature miRNA are in 






Figure 3. Relative luciferase activity in comparison to control are presented. 
With increase in pre-miR285-3p reduction in luciferase activity was observed. Results are 















The role of non-coding RNA and epigenetic mechanisms can help explain details of regulation of 
gene expression. Fig. 1 briefly explains the various mechanism actively controlling gene 
expression at both transcriptional and post-transcriptional levels. Besides established regulatory 
mechanisms including cis and trans elements, splicing, alternative splicing, poly (A) length, 
mRNA export and decay; epigenetic mechanisms and non-coding RNA govern gene expression at 
additional levels. The current study to understand how non-coding RNAs and DNA methylation 
contribute to imbalance in protein turnover in E2 treated rainbow trout. The observations support 
that these molecular elements are highly influenced by external stimuli like E2 at 24 hours. Thirty-
six miRNAs were differentially expressed between control and E2 treated samples within 24-hours 
of treatment. These effects were diluted after 72 hours of treatment as determined by miRNA 
expression and gene expression experiments. These pieces of evidence signify the rapid influence 
of external stimuli and their regulation of molecular mechanisms. Further, the previous 
observations of increased protein degradation and decreased protein synthesis were because of 
changes at the molecular levels. Differential expression of miRNA contributing to protein 
degradation and protein synthesis were observed (Fig. 4). Target genes of these differentially 
expressed miRNA are involved in stem cell proliferation, maintenance and control of phase 
transition in mitosis, maintenance of mitochondrial outer membrane permeability, apoptosis and 
atrophy. Increased expression of Pax7 involved in muscle precursor (stem) cell proliferation (Fig. 
2), caspase 9, caspase 3 (downstream enzymes expressed as an effect of MOMP leading to 
apoptosis) and fbxo32 (Fig. 3) was observed. All together miRNA study indicates the role of small 
RNA in regulation of gene expression contributing to available evidences of protein metabolism 
in E2 exposed skeletal muscle (Fig. 4).  
Further no differentially expressed miRNA directly explain decreased expression of 
MyoD, that helps in differentiation of MPCs. Hence efforts to understand the contributing factors 
affecting regulation MyoD gene expression were performed by focusing on DNA methylation 
(Fig. 4). Differential non-CpG methylations were observed between control and E2 samples in 
exon 1 of MyoD. These methylations were also part of transcription factor binding elements Myc 
and ERE indicating their role in gene regulation.  Moreover, one of the novel differentially 
expressing miRNA identified regulate expression DNA methyltransferases (DNA methylation 
enzymes). These observations directed our focus to understand changes in global DNA 
methylation after 24 hours of E2 treatment. Cytosine methylations were identified in CG, CHG 
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and CHH contexts at global level but further analysis was carried out by CG methylations. More 
than 200 genes were identified to be differentially methylated between control and E2 samples. 
These genes are involved in signal transduction, ion binding, cellular metabolism, cell 
communication, development of cellular anatomical structures, response to stimuli and enzyme 
activity (Fig. 5). Some of the interesting genes that are differentially methylated include TATA 
box-binding -associated factor RNA polymerase I subunit B, pre-mRNA-processing factor 19, 60S 
ribosomal L19, E3-ubiquitin ligases etc. To better understand the direct effects of DNA 
methylation on independent genes additional studies are necessary. Such studies would help in 
gaining knowledge to identify specific role of these genes that are collectively contributing to 











Figure 1. Regulation of gene expression at transcriptional and post-transcriptional levels. 
Genetic and epigenetic mechanisms regulate gene expression which are independently studies but 








Figure 2. Increase in self renewal of MPCs. 
An increase of MyoD and decrease in Pax7 is necessary for MPCs to differentiate further to form 
a mature muscle fiber. In our study, an increase in Pax7 is observed with decrease in MyoD 





Figure 3. Increase in apoptosis and atrophy. 
miR-23a-3p is predicted to regulate the expression of fbxo32 and outer membrane integrity. In the 
presence of E2 decrease in this miRNA resulted in increased fbxo32 expression and MOMP 





Figure 4. Identified regulatory mechanisms resulting in imbalance in protein turnover under 
the influence of E2. 
Shown are different genes contributing to imbalance and their direct or indirect regulatory 
mechanisms. No direct evidence for regulation of Pax 7 by miR-17 and 20a cluster was found, 









In the past gene expression was believed to be regulated solely by the order of nucleotide 
bases in a genome and their cis and trans regulatory factors. Recent advancement in the field 
established the role of additional modifications occurring on the genome, referred to as epigenome. 
These chemical modifications are inheritable but reversible and include DNA methylation, histone 
modifications and chromatin remodeling which are influenced by environmental, nutritional, 
physical and developmental changes. Convincing pieces of evidence are available indicating that 
these epigenetic modifications alter gene expression. Added to the list of epigenetic modifications 
are microRNAs and long noncoding RNAs with similar function.  
Observations from current study indicates the influence of environmental factors (feed, 
estrogen) on gene expression though epigenetics and microRNAs. An initial understanding of 
epigenetic landscape in skeletal muscle was achieved during our study. Increase in MPC 
proliferation and decrease in differentiation was observed as an influence of E2 on skeletal muscle. 
MyoD expression in E2 treated samples at 72 hours reached to similar levels of control probably 
due to loss of methylation and activation of gene. It will be interesting to know if these changes in 
fish are exceptional due to energy demand during spawning or a signal to address recovery after 
spawning or both. Increase in degradative pathways support the energy needs to be addressed 
during these phases. Our experiments detail about muscle exclusively without considering other 
organs and their interaction during these processes. As muscle is believed to be one of the major 
available energy sources besides fat during these phases, assessing the expression of these 
molecular markers in various reproductive phases of fish will help gain further understanding.  
Metabolism of various amino acids were differentially regulated in E2 skeletal muscle 
compared to control. Genes involved in metabolism of amino acids including lysine, phenylalanine 
methionine, threonine, cysteine, glycine, serine, alanine and tyrosine were differentially 
methylated. Understanding the role of DNA methylation in regulating these pathways would 
primarily lead to our understanding in the role of external stimuli on amino acid metabolism. 
Further its important to also know if supplementing any of these amino acids will be sufficient to 
address the energy demands by rainbow trout. Some of the above listed amino acids are essential 
which are to be supplemented by diet. Insufficient supply of those amino acids during 
vitellogenesis and spawning through feed might lead to protein breakdown to address the amino 
acid demands.  
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Overall these reproductive phases cause stressful situations for fish that modify epigenetic 
landscape. Another area to explore is to see the effects of transgenerational epigenetics in fish. 
Does any of these epigenetic effects pass over to next generation and if so how are these changes 
changing the muscle quality? The identified epigenetic markers supporting rapid muscle 
degradation are not only confined to effects of E2 on skeletal muscle in fish but can also be tested 
during stress or disease conditions leading to muscle loss. Furthermore, this study also provided 
understanding of basic epigenetic mechanisms in rainbow trout skeletal muscle development. 
Teleost fish like rainbow trout is capable of regenerating muscle by both hyperplasty and 
hypertrophy, unlike mammals. Furthering an investigation of the molecular mechanisms 
underlying and regulating differences in hypertrophy and hyperplasty will be fascinating. These 
findings will help explain the inability of increase in muscle fibers number during adult 
myogenesis in mammals, with possible applications in addressing mammalian muscular diseases 
and injury.  
Availability of advanced and cost-effective techniques are necessary to take complete 
advantage of epigenetics and close assessment of specific stages to understand these modifications 
is important. Likewise, the availability of a well annotated genome would help better understand 
the changes and their importance. This knowledge would also help in designing new feed and 
feeding strategies. Similarly, assessing the available commercial feed in terms of available protein 
composition. Determination of these changes from early stages and their effects in development 
to maturation where heritable changes might affect subsequent generations. It is important to 
understand added epigenetic effects to genetic effects for more accuracy in selective breeding and 
genetic improvement. Finally, advances in epigenetic studies may lead to the development of 
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